Biophysical characterization of reactions associated with reverse cholesterol transport by Zehender, Fabian
  
 
Biophysical Characterization of Reactions Associated with 
Reverse Cholesterol Transport 
 
 
INAUGURALDISSERTATION 
 
zur 
Erlangung der Würde eines Doktors der Philosophie 
vorgelegt der Philosophisch-Naturwissenschaftlichen Fakultät  
der Universität Basel 
 
 
von 
Fabian Zehender 
aus 
Freiburg, Deutschland 
 
Basel, 2012 

 Genehmigt von der Philosophisch-Naturwissenschaftlichen Fakultät auf Antrag von  
 
Prof. Dr. Joachim Seelig 
Prof. Dr. Anna Seelig 
Prof. Dr. Jörg Huwyler 
 
 
Basel, den 21. Februar 2012 
            
      ________________________________ 
      Prof. Dr. Martin Spiess (Dekan) 
 

Index 
5 | P a g e  
 
1. Summery and Rationale ......................................................................... 7 
2. Thermodynamics of protein self-association and unfolding. The case 
of Apolipoprotein A-I  ................................................................................ 11 
Published Article .......................................................................................................... 12 
Appendix: Dynamic light scattering and analytical ultracentrifugation with 
Apo A-1 ......................................................................................................................... 61 
Dynamic light scattering (DLS) ................................................................................. 61 
Analytical ultracentrifugation .................................................................................... 64 
3. Lipid binding of Apo A-1 mimetic peptides ....................................... 75 
Introduction .................................................................................................................. 75 
Materials and Methods ................................................................................................ 79 
Materials .................................................................................................................... 79 
Methods ...................................................................................................................... 79 
Results ........................................................................................................................... 83 
Association behavior of peptides 4F and P ................................................................ 83 
Binding of peptides 4F and P to lipid membranes ..................................................... 92 
References ................................................................................................................... 122 
Appendix ..................................................................................................................... 127 
4. Towards understanding of the allocritee specificity of the lipid 
floppase ABCA1 ......................................................................................... 133 
Preliminary manuscript ............................................................................................ 134 
5. Acknowledgements ............................................................................. 171 
6. Curriculum vitae ................................................................................. 173 
7. Declaration ........................................................................................... 175 

1. Summery and Rationale 
7 | P a g e  
 
 
1. Summery and Rationale 
 
This thesis aimed at improving our understanding of reactions relevant in the reverse 
cholesterol transport (RCT). RCT facilitates cholesterol homeostasis and is the most 
important pathway involved in cardiovascular disease. For this purpose three different 
projects were chosen. Thermodynamics of protein self-association and unfolding was 
characterized in detail at the example of Apolipoprotein A-1 (Apo A-1). Lipid binding 
was characterized by means of small peptides that mimic Apo A-1 function. The third 
project gained insight about the molecular mechanisms of ABCA1`s allocritee flopping. 
Apo A-1 is the main protein constituent of high density lipoprotein (HDL) and is 
together with ABCA1 a key player of the RCT. 
 
Apolipoprotein A-1 
Protein self-association and unfolding are two processes whose understanding is of 
utmost importance for the development of biological phamaceuticals as oligomerisation 
may alter functional properties of proteins. Apo A-1 is a perfect candidate for these 
investigations as it undergoes a concentration dependent self-association process and 
has high physiological relevance. Even though Apo A-1 is a highly investigated 
macromolecule, self-association was not investigated in such a comprehensive 
approach. Additionally, we used highly purified recombinant human Apo A-1, which 
was generously provided by H.-J. Schönfeld. For analyzing thermodynamics of self-
association and thermal unfolding we introduced new theoretical and experimental 
methods  
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Self-association data was obtained by a combination of high sensitivity micro 
calorimetry and analytical ultracentrifugation. The dissociation reaction of highly 
concentrated and thus oligomeric Apo A-1 was followed by injection into buffer in an 
isothermal titration calorimeter (ITC). Dilution of the sample moved the chemical 
equilibrium towards monomers. Complementary, this equilibrium was analyzed by data 
obtained from analytical ultracentrifugation in a sedimentation equilibrium mode. If 
any, self-association was described in former studies as equilibrium between distinct 
species, for example between monomers and dimers. We introduced a cooperative self-
association model that describes the equilibrium of the protein between each possible 
oligomer in a concentration dependent manner. Furthermore, we introduced a “binding 
partition function” that represents the sum of all concentrations found in the system. 
Together with a dissociation degree of the protein we found a link between 
thermodynamic data and theory of self-association. The binding partition function 
describes the statistical properties of the system in thermodynamic equilibrium. Hence, 
it is independent of the theoretical model that is utilized to describe the reaction. 
Thermal unfolding of Apo A-1 was followed by circular dichroism spectroscopy (CD) 
and differential scanning calorimetry (DSC). We found that melting of Apo A-1 caused 
a transition of α–helix to β–sheet and random coiled secondary structure and appeared 
to be highly reversibly up to 75 °C. Thermal unfolding of Apo A-1 and in general of 
proteins is analyzed almost exclusively with an all-or-none model. As a powerful 
alternative for higly α–helical proteins such as Apo A-1, we introduced the cooperative 
Zimm-Bragg theory. Zimm-Bragg theory is commonly used for thermal unfolding of 
peptides, but fits well to our data and to data of other proteins obtained from literature.  
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Apo A-1 mimetic peptides 
Apo A-1 was proposed as drug against cardiovascular disease. However, Apo A-1 
mimetic peptides are more promising as they have to be administered in much lower 
dosage and are produced more easily. Understanding their lipid binding properties is 
essential for the estimation of in vivo effects as well as for formulation and dosage of 
possible drugs with these peptides. Apo A-1 structure is featured by several amphiphatic 
class A motif α-helices. Even though it is the main protein component of HDL, 
thermodynamic characterization of its lipid binding has not been achieved in detail. As a 
model of Apo A-1 we used two peptides (4F and P), which are featured by class A 
amphipathic α-helical sequences. 4F showed Apo A-1 mimetic properties in animal 
models and clinical studies. We used isothermal titration calorimetry to determine 
thermodynamic parameters of binding to POPC lipid vesicles. In order to understand 
this reaction several other experimental methods were used. Static and dynamic light 
scattering illustrated the ability of the peptides to rupture unilamellar vesicles and form 
micellar-like particles. In contrast, many other peptides such as cell penetrating peptides 
(CPPs) only partition into the membrane. This finding is in agreement with a 1:1 lipid-
to-peptide stochiometry yielded from ITC data analyzed with a model of n identical 
binding sites. This behavior might have high physiological relevance as possible rupture 
of cell membranes is unwanted. Circular dichroism experiments yielded insight into 
structural transitions as part of the driving force of lipid binding. Associated with lipid 
binding is a transition of the peptide from β–sheet and random coiled to α-helical 
secondary structure. Tryptophan fluorescence measurements complemented the studies 
indicating binding to lipids as well. Thermodynamic calculation proved the structural 
transition of β–sheet and random coiled to α-helix as well as hydrophobic interactions 
as driving forces of the reaction. 
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Further, we studied binding of the peptide 4F to cholesterol by means of ITC. Our 
results suggested affinity of 4F towards cholesterol but with lower affinity compared to 
POPC. This might explain the formation of HDL like particles, mainly consisting of 
phosphocholine lipids. These particles, in turn, could bind to cholesterol with high 
affinity.  
 
ABCA1 
ABCA1 is an ATP binding cassette transporter that flops excess lipids of a cell to the 
outer membrane leaflet, where it can be picked up by Apo A-1 or HDL particles. 
Research in the field of ABCA1 is mainly focused on studies in cell culture and in 
animal models and is therefore rather indirect. Cholesterol efflux by ABCA1 was 
assumed to be controlled by the copy number of the transporter. The possibility of a 
direct modulation of the transporter activity by allocrites like in P-glycoprotein (Pgp) as 
well as the proposed allocrite specificity was rarely investigated in previous studies. 
Here, we measured the ATPase activity of inside-out vesicles prepared from ABCA1 
transfected Human Embryonic Kidney 293 cells by means of a spectroscopic phosphate 
release assay. Aluminum fluorides were found as strong inhibitor of the nucleotide 
binding sites (NBD) of ABCA1 in contrast to vanadate. Furthermore, a screening for 
putative allocrites interacting with the transmembrane domains (TMDs) was performed 
with numerous compounds. Therewith we found that all compounds with a pegylated 
chain, a heterocyclic group and a hydrocarbon tail indicated activation of the ABCA1 
ATPase. 
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Published Article 
 
Abstract 
Protein self-association and protein unfolding are two temperature-dependent 
processes whose understanding is of utmost importance for the development of 
biological pharmaceuticals since protein association may stabilize or destabilize protein 
structure and function. Here we present new theoretical and experimental methods to 
analyze the thermodynamics of self-association and unfolding. We used isothermal 
dilution calorimetry and analytical ultracentrifugation to measure protein self-
association and introduced binding partition functions to analyze the cooperative 
association equilibria. In a second type of experiment we monitored thermal protein 
unfolding with differential scanning calorimetry and circular dichroism spectroscopy 
and used the Zimm-Bragg theory to analyze the unfolding process. For α-helical 
proteins the cooperative Zimm-Bragg theory appears to be a powerful alternative to the 
classical two-state model. As a model protein we chose highly purified human 
recombinant apolipoprotein A-I. Self-association of Apo A-1 showed a maximum at 
21 °C with an association constant Ka = 5.6 × 105 M-1, a cooperativity parameter σ = 
0.003, and a maximum association number N = 8. The association enthalpy was linearly 
dependent on temperature and changed from endothermic at low temperatures to 
exothermic above 21 °C with a molar heat capacity 0pC∆ = -2.76 kJ/molK. Above 45 °C 
the association could no longer be measured because of the onset of unfolding. 
Unfolding occurred between 45 °C and 65 °C and was reversible and independent of 
protein concentration up to 160 μM. The midpoint of unfolding as measured by DSC 
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was T0 = 52-53 °C, the enthalpy of unfolding UNH∆ = 420 kJ/mol. The molar heat 
capacity increased by UN pC∆  = 5.0 ± 0.5  kJ/molK upon unfolding corresponding to a 
loss of 80 to 85 helical segments, as was confirmed by CD spectroscopy. Unfolding was 
highly cooperative with a nucleation parameter σ = 4.4 × 10-5. 
 
Introduction 
In situ, biological molecules are confronted with a spectrum of structures, 
concentrations, ions, etc., a situation thermodynamically distinct from dilute solutions in 
vitro. Macromolecular crowding may lead to non-specific homo- or hetero-association 
and an understanding of functional mechanisms requires quantitative analysis of protein 
association equilibria. The thermodynamic treatment of coupled reactions with many 
intermediates is a complex process, as temperature changes influence both the 
association equilibrium and protein stability. Here we consider protein association and 
protein unfolding as two independent cooperative processes. The protein 
association/dissociation equilibrium is described as a multi-state process using binding 
partition functions. Protein unfolding is analyzed with the nearest-neighbor Zimm-
Bragg theory and compared to the classical two-state N  U model. We apply these 
theoretical models to experimental data obtained with Apolipoprotein A-I (Apo A-I).   
Apo A-I, a 28.2 kDa protein, reduces cardiovascular risks by promoting the 
reverse transport and metabolism of cholesterol. Its structural and functional properties 
with and without lipid have been intensively investigated (for reviews see [40] and 
[41]). X-ray diffraction and CD spectroscopy demonstrate that Apo A-I contains long 
stretches of α-helical structure [42-47]. α-Helix is enhanced after lipid binding [48]. 
Analysis of the thermodynamics of lipid binding reveal that the association number [49] 
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and lipid-to-protein ratio [50] markedly influence the shape of reconstituted particles 
suggestive of functional differences. The association equilibrium of lipid-free Apo A-I 
is however an area of ambiguity with diverging reports on its association number and 
association mechanism (for a recent survey see [51]).  
We investigated the above mentioned variability with highly purified recombinant 
human Apo A-I. The monomer-oligomer equilibrium was investigated with high 
sensitivity titration calorimetry (ITC). By diluting concentrated Apo A-I solutions in the 
calorimeter cell it was possible to determine the association enthalpy, 0aH∆ , association 
constant, Ka, and association number, n, of oligomer formation as a function of 
temperature. Sedimentation equilibrium runs in the analytical ultracentrifuge (AUC) 
provided an independent approach to elucidate the association constant and 
stoichiometry. We propose a cooperative association model and develop analytical 
expressions for the degree of dissociation and molar heat capacity change upon 
oligomer dissociation. 
 CD spectra were recorded as a function of protein concentration and temperature 
to monitor structural changes. Differential scanning calorimetry was used to quantify 
the thermodynamics of protein unfolding. Taking into account changes in molar heat 
capacity upon unfolding and using the cooperative Zimm-Bragg model for α-helix-coil 
transitions it was possible to correlate structural changes observed by CD spectroscopy 
with thermodynamic DSC data. Apo A-I unfolding was found to thermodynamically 
override Apo A-I association. 
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Materials and Methods 
Proteins. A detailed protocol fort medium scale preparation of recombinant 
human Apo A-I will be published in different context (Schönfeld et al., manuscript in 
preparation). Briefly, a fusion protein construct involving a hexahis purification tag, an 
ubiquitin sequence, a granzyme B cleavage site (IEPD¦GG) and the human Apo A-I 
sequence (N- to C-terminus) was recombinantly expressed in E.coli. 
After opening of cells by French press treatment the recombinant fusion protein 
was bound to a Ni-NTA column and then washed with alternating cycles of two buffers, 
one containing 8 M urea and the other containing 60% isopropanol to remove bacterial 
endotoxins. The fusion protein was eluted using EDTA, cleaved with Granzyme B and 
the hexahis tag containing N-terminus was removed from the mixture by a second 
NiNTA affinity step. Recombinant protein that did not bind to NiNTA contained the 
authentic human Apo A-I sequence with two additional glycines at the N-terminus. The 
Apo A-I protein was further purified by anion exchange chromatography and then 
extensively dialyzed against PBS. Purified Apo A-I contained no significant amounts of 
aggregates as analyzed by SEC with on-line static light scattering and no detectable 
endotoxins as measured by limulus assay. Purified recombinant Apo A-I sequence 
differed from human wild-type Apo A-I sequence by two additional N-terminal glycine 
residues. Electrospray mass spectrometry revealed a molecular mass of 28192.3 Da 
(theoretical value for wt Apo A-I + 2 Gly is 28192.7 Da). Comparison by size exclusion 
chromatography (data not shown) and analytical ultracentrifugation (Figure 3C) did not 
reveal any higher order structure differences between recombinant Apo A-I and Apo A-
I purified from human plasma, a generous gift from Dr. Tim Tetaz, Roche Basel. 
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Circular dichroism (CD) spectroscopy. CD spectra were obtained with a CD 
spectrometer Model 62 ADS (AVIV, Lakewood, N.J.) in the wavelength range of 190 
nm - 260 nm using a total acquisition time of 25 min per spectrum. Measurements were 
made with protein concentrations of 0.1 mg/mL and 0.5 mg/mL in 100 mM NaF, 10 
mM sodium phosphate, pH 7.4. Quartz cuvettes with path lengths of d = 1 mm and 0.2 
mm were used and a baseline with pure buffer was recorded for each cuvette and 
subtracted from the protein spectra. The CD-spectra were simulated with the non-
commercial software CDpro [52] based on reference spectra of 56 proteins (data set # 
10) and also with an Excel program based on a linear combination of reference spectra 
[53]. The melting behavior of Apo A-I was studied in the range of 25 - 85 °C.  
 
High sensitivity isothermal titration calorimetry (ITC). ITC was performed using 
either the ITC-200 or the VP titration calorimeter from Microcal (Northampton, MA). 
The cell volumes were 200 μL and 1.4 mL, respectively, and the injection volume 
varied between 2 μL and 10 μL. Solutions were degassed under vacuum for about 10 
min. The calorimeter cell contained buffer and the protein solution (80 μM or 160 μM) 
was in the injection syringe. The injection of small amounts of a concentrated Apo A-I 
solution into buffer led to the dissociation of Apo A-I complexes. The heat flow induced 
by protein dissociation is recorded and analyzed by the software provided with the 
instrument. The quantitative interpretation of the Apo A-I dissociation isotherm in terms 
of thermodynamic parameters was not part of the commercial software and is discussed 
below. All measurements were made in PBS buffer (137 mM NaCl, 10 mM sodium 
phosphate, pH 7.4, 0.02% NaN3). 
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Differential scanning calorimetry (DSC). DSC scans were made with a VP-DSC 
(Microcal, Northampton, MA). Protein solutions were degassed and the reference cell 
contained only buffer. The heating rate was 1 °C/min. DSC scans were made in PBS 
buffer, pH 7.4, with 0.02% NaN3. Further evaluation of the DSC curves was performed 
as described in the Results section.  
 
Analytical ultracentrifugation (AUC). A Beckman XL-I ultracentrifuge (Beckman 
Coulter, Indianapolis, IN) with UV- and Interference detection systems was used. 
Protein solutions were measured in PBS buffer at concentrations from 0.5 to 2 mg/mL 
with 0.02% NaN3. Sedimentation velocity (SV) and sedimentation equilibrium (SE) 
measurements were done at 20 °C. Depending on protein concentration, the center piece 
length was 1.4, 3, or 12 mm. Rotational speeds in SE runs were between 5 and l8 krpm. 
Using a liquid column height of ~5 mm equilibria were reached within ca. 68 h, as 
verified by comparison with subsequent radial scans.  
 
Theory 
Analysis of calorimetric protein unfolding experiments. The calorimetric enthalpy 
of the unfolding process N  U is temperature-dependent and can be calculated by 
( )U 0 UN U N p 0H(T) f (T) H C T T ∆ = ⋅ ∆ + ∆ −   (1) 
 
fU= (1 - fN) is the fraction of unfolded protein (0 ≤ fU ≤ 1), ΔH0 is the unfolding 
enthalpy, UN pC∆  is the difference in the molar heat capacity between the native and the 
unfolded protein, and T0 is a reference temperature, usually the midpoint of the 
unfolding curve. The heat capacity change measured in the DSC calorimeter is given by 
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( )U U 0 U UN p U N p N p 0
df (T)C (T) f (T) C H C T T
dT
 ∆ = ⋅∆ + ∆ + ∆ −   (2) 
 
In the following we use two models to calculate the extent of unfolding fU.  
The classical model for protein unfolding is the N  U two-state model. The 
fraction of unfolded protein is related to the temperature-dependent equilibrium constant 
[ ] [ ]UNK (T) U / N=  according to  
U
N
U U
N
K (T)f (T)
1 K (T)
=
+
 (3) 
 
At the midpoint T0 of the transition, enthalpy and entropy are equal. The free energy 
change of unfolding, UNG(T)∆ , can be written 
U 0 U
N N p 0
0 0
T TG(T) H 1 C T T ln
T T
   
∆ = ∆ − + ∆ − +   
   
 (4) 
 
The temperature-dependence of the equilibrium constant is given by 
U
NG(T)
U RT
NK (T) e
−∆
=  (5) 
 
 The three independent parameters which need to be determined are 0 UN pH , C∆ ∆ , and 
T0. The temperature T0 designates the midpoint of the N  U transition where 
U
N 0G(T ) 0∆ =  and 
U
N 0K (T ) 1= . ΔH
0 is the van't Hoff enthalpy of the transition and must 
be distinguished from the calorimetric enthalpy ΔHcal which is measured by the DSC 
instrument. In an ideal fit of the N  U model the two quantities are identical. 
However, if ΔH0 and ΔHcal are different, the deviation of ΔH0/ΔHcal from unity is 
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considered to be indicative of intermediates in the transition. The calorimetric curve is 
then approximated by a superposition of several N  U transitions. 
The N  U model does not completely reveal the molecular aspects of protein 
unfolding. However, many proteins - such as Apo A-I - have a high α-helix content and 
a specific molecular process of unfolding is the cooperative "melting" of the α-helix. 
We therefore propose an alternative description of Apo A-I unfolding in terms of the 
cooperative α-helix  random coil transition and we will extend this model to include 
β-structure formation. The degree of unfolding, fU (T), is calculated with the Zimm-
Bragg matrix method [54] and combined with equations (1) and (2). The Zimm-Bragg 
model considers the α-helix  random coil transition as the cooperative disruption of n 
hydrogen bonds. It is an enthalpy-driven process and the enthalpy change in breaking a 
single helical hydrogen bond is in the range of h = 3.8 kJ/mol (0.9 kcal/mol) to 5.4 
kJ/mol (1.3 kcal/mol) [55-57]. While h itself is independent of temperature, the 
temperature dependence of the equilibrium constant s(T) (growth parameter) follows 
van't Hoff's law according to 
1
h 1 1
R T Ts(T) e
 
− 
 =  (6) 
 
At T1 the growth parameter s is s(T1) =1. T1 defines the midpoint of the α-helix  
random coil for a sufficiently long and highly cooperative polypeptide chain. Under 
these conditions T1 is identical with the experimentally observed midpoint T0. However, 
the chain length n has a dramatic effect on the melting behavior. Short chains melt at 
lower temperatures than long chains and the theory then predicts the midpoint 
temperature T0 at lower temperatures than T1. 
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The second parameter in Zimm-Bragg theory is the nucleation factor σ which is 
related to the probability of forming an α-helix nucleus within a random coil sequence. 
σ determines the cooperativity of the system and is assumed to be temperature-
independent.  
 Zimm-Bragg theory defines conditional probabilities for extending a given 
peptide chain by one additional segment where "segment" in the present context is 
identical to a single amino acid in the protein sequence. Adding a helix segment to an 
existing α-helix requires the growth parameter s; formation of an α-helix nucleus within 
a random coil sequence is defined by the nucleation parameter σs. The occurrence of a 
coil segment has the probability 1. In the nearest neighbor approximation these 
conditional probabilities can be summarized in the probability matrix M [54, 58]. 
1 1
M
s s
 
=  σ 
 (7) 
 
The partition function of a chain of n segments is then given by 
( ) n
1
Z 1 1 M
0
 
=  
 
 (8) 
 
Knowledge of the partition function allows the calculation of the α-helix fraction 
according to  
h
1 ln Zf
n s
∂
=
∂
 (9) 
 
As s is a function of temperature, M, Z, and fh are equally temperature-dependent. The 
fraction of unfolded protein is 
fU(T) = (1 - fh) (10) 
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fU (T) can then be combined with equation (2) to calculate UN pC (T)∆ .  
A convenient approach to calculate the helix-fraction is eq. (27) of reference [54] 
which can easily be programmed.  
 
Association/dissociation equilibrium of Apo A-I. The association of Apo A-I is a 
separate process which must be distinguished from unfolding. It is described here by a 
chemical model which includes cooperativity and growth and has been applied 
successfully to describe surfactant association in micelles [59]. 
A + A → A2; A2 + A → A3; … →An   
 
The formation of the dimer A + A  A2 is the nucleation step 
2
2
A a Ac K c= σ ⋅  (11) 
 
which is followed by several growth steps 
3 2
2 3
A a A A a Ac K c c K c= ⋅ = σ  (12) 
n n 1A a A Ac K c c−= ⋅ ⋅  (13) 
 
σ is the nucleation parameter (different from that of Zimm-Bragg theory) and cA is the 
monomer equilibrium concentration. The equilibrium constant Ka is temperature-
dependent according to van't Hoff's law. The corresponding enthalpy of association, 
0
aH∆ , is also temperature-dependent and is written as  
( )0 0 0a a p,a 0H (T) H C T T∆ = ∆ + ∆ −  (14) 
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T0 is an arbitrary reference temperature. 0p,aC∆  is the molar heat capacity change of the 
association reaction. All numerical values refer to protein monomers. 
If 0Ac  is the total concentration of monomer A and q = KacA defined as growth 
parameter, mass conservation requires 
n
0 j 1
A A
j 2
c c 1 j q −
=
 
= + σ  
 
∑  (15) 
 
We introduce a binding partition function Q which represents the sum of all 
concentrations found in the system referenced to the monomer concentration cA (cf. 
[60]) 
2 n
n
j 1
A A A A A
j 2
c c ...c c 1 q c Q−
=
 
+ + = +σ = ⋅  
 
∑  (16) 
( )
( )
Nn
j 1
j 2
q q
Q 1 q 1
1 q
−
=
σ −
= +σ = +
−∑  (17) 
 
The degree of dissociation (fraction of monomers) at a given total concentration, 0Ac , is 
given by 
A
0
A
c
c
α =  (18) 
 
and can be calculated as 
1
Qq Q
q
−
 ∂
α = + ∂ 
 (19) 
 
The temperature-dependence of α is given by 
10
* * 0a
a A2 2
H (T)d 1qQ Q K c
dT RT
−∆α  = − − ⋅ α 
 (20) 
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where 
2
*
2
Q QQ 2 q
q q
∂ ∂
= +
∂ ∂
 (21) 
 
We now consider a thought experiment where the protein is locked in its native 
conformation and a change in temperature influences only the association equilibrium 
but not the protein conformation. If performed in the DSC instrument the molar heat 
capacity change is predicted as: 
0
p,a p,a a
dC (T) C H (T)
dT
α
∆ = ∆ ⋅α + ∆ ⋅  (22) 
 
Knowing the temperature dependence of ΔHa and Ka, the degree of dissociation, α, and 
the molar heat capacity change, ΔCp,a, can be predicted.  
For completeness we mention two alternative association models which are 
discussed in the literature in connection with Apo A-I. The first is the all-or-none model 
nA  An (23) 
 
which can be described by 
n
n n 1
A A ac / c K
−=  (24) 
 
Defining again 
q = cA Ka  (25) 
 
this leads to the binding partition function 
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Q = 1 + qn-1  (26) 
 
where the degree of dissociation can again be calculated with eq. 19.   
The second model suggests a monomer-dimer-tetramer-hexamer-octamer 
equilibrium [61]. In the present notation the binding partition function of this model is 
given by 
( )
2n 1n 1
2 j 1
2
j 1
q qQ n = 1+ σ q 1
1 q
−−
−
=
−
= + σ
−
∑  (27) 
 
The nucleation parameter is included for generality and must be defined as σ = 1 to 
make eq. (27) equivalent to the above mentioned model of reference [61]. Again eq. 
(19) can be used to derive the degree of dissociation α. 
 
Results 
Isothermal titration calorimetry (ITC) of Apo A-I monomer  oligomer 
equilibrium. Apo A-I self-associates in solution even at low protein concentrations [51, 
61, 62], but thermodynamic aspects of Apo A-I self-association have not yet been 
investigated in detail. The availability of high-sensitivity titration calorimetry now 
permits the deduction of the enthalpy of association, ∆Ha, binding constant, Ka, and 
association number, n, from dilution experiments. The calorimetric titration sequence is 
analogous to detergent demicellization experiments determining the critical micellar 
concentration [59, 63]. In the present study, the dilution involves oligomers of different 
size and the stoichiometry is not known. Also not known is the effect of temperature on 
the association-dissociation equilibrium.    
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Figure 1A displays the heat flow in a dilution experiment where Apo A-I (160 
μM) was injected into PBS buffer. At 40 °C the heat of dissociation was endothermic 
but changed to exothermic when the experiment was performed below 20 °C. 
Integration of the calorimetric response peaks yielded the heats of reaction, δhi (Fig. 
1B). The first protein injection corresponded to a more than 100 fold dilution of the 
starting solution and resulted in a 
 
Figure 1 
 
complete dissociation of the Apo A-I complex. The molar heat of dissociation is then 
given by  
1hH
n
δ
∆ =
δ
 (28) 
 
where δh1 is the measured heat of dissociation of the first injection and δn is the molar 
amount of injected Apo A-I.  
However, the experimentally derived ΔH is not the full molar heat of dissociation, 
0
DH∆ . The thermodynamic and statistical analysis discussed below shows that the 160 
μM Apo A-I solution is composed of Apo A-I complexes (~95%) and a small fraction 
of monomers (~5%). The true heat of dissociation, 0DH∆  is thus larger than the 
measured value ΔH. The correct value follows from the theoretical analysis of the 
dissociation isotherm as described in more detail below. Table 1 shows the measured 
ΔH and the corrected heat of association, 0 0a DH H∆ = −∆ . 
0
aH∆  has the opposite sign of 
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the heat of dissociation. Taking into account the fraction of monomers, α, 0aH∆  is given 
by 
0
aH∆  = -ΔH/(1 – α) (29) 
 
 
Table 1 
 
Continued addition of Apo A-I to the calorimeter cell causes dissociation to stop. 
The degree of dissociation, αi, after i injections is given by 
i
i
i
1
h
i h
δ
α =
δ
∑
 (30) 
  
The nominator is the cumulative heat measured for the first i injections, the 
denominator is the predicted maximum heat, i · δh1, expected for complete dissociation 
after i injections. The ITC dilution experiment thus provides both the dissociation 
enthalpy, 0DH∆ , and the dissociation isotherm ( )0pf cα = . 0pc  is the total concentration 
of protein in the calorimeter cell and increases with each injection. 
ITC measurements were performed between 5 and 45 °C and Fig 2A displays the 
temperature dependence of the association enthalpy 0aH∆ . The enthalpy changes its sign 
at  
 
Figure 2 
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about 20 °C and the slope of the straight line yields the molar heat capacity change for 
the association reaction as 0pC∆ =  -2.76 kJ mol-1K-1 (-0.66 kcal mol-1K-1).  Apo A-I 
self-association is thermodynamically similar to the partitioning of hydrophobic 
substances between water and an organic phase [64]. The enthalpy of dissolving 
hydrophobic substances such as hexane in water is close to zero at room temperature 
while the heat capacity increment for the transfer from water into pure organic phase is 
large and negative. Apo A-I self-association paralleled this behavior, as the enthalpy of 
Apo A-I self-association was zero at room temperature and the heat capacity change 
strongly negative. Calorimetric experiments at 15-30 °C were not feasible because 0aH∆  
~ 0 kcal/mol.  
Apo A-I dissociation as measured by ITC was analyzed with the cooperative 
association model. The result is shown in Fig. 1B (solid line) which simulates the 
dilution measurement at 40 °C and was calculated with an association constant Ka = 3.5 
× 105 M-1, a nucleation factor σ = 0.003 and a maximum association number n = 8. An 
excellent fit between theory and experiment was obtained.   
The cooperative model was further applied to investigate the influence of the 
association number 'n' on the quality of the simulation. A minimum of n = 6 was 
required to generate a good fit of the ITC data over the whole temperature range. An 
increase in n from 6 to 20 provided simulations of similar quality, but reduced the 
values of the nucleation parameter σ and the association constant Ka. At n = 20 a 
'plateau' was reached where an increase in n had no further effect on σ or Ka. However, 
analytical ultracentrifugation data discussed below argue against an association number 
larger than n = 8.  
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Fig. 2B shows the temperature dependence of the Apo A-I association constant Ka 
(addition of a monomer to an existing complex) for n = 8. The solid line is the predicted 
temperature dependence of Ka calculated with the van't Hoff equation and a 
temperature-dependent 0aH∆  (Fig. 2A). The simulations also showed that a nucleation 
parameter σ << 1 was essential for the correct interpretation of the experimental data. 
Initial dimer formation is thermodynamically less favored than the addition of 
monomers to an existing complex. 
As an alternative model we also evaluated the all-or-none model. A fit of the ITC 
data was possible with n = 6. However, the model assumes only monomers and 
hexamers without intermediates, is kinetically impossible, and disagrees with the results 
of analytical ultracentrifugation. 
 
Analytical ultracentrifugation (AUC) analysis of Apo A-I self-association. 
Previous studies on Apo A-I self-association used AUC measurements of serum-
purified Apo A-I [61, 65]. We therefore compared the recombinant Apo A-I (with two 
additional C-terminal glycines) used in this study with serum-purified Apo A-I also 
using AUC. Fig. 3A shows sedimentation equilibrium runs at 6, 8 and 10 krpm for 
recombinant Apo A-I (160 μM) in PBS buffer. The protein concentration increases with 
increasing radius r, and thus each point in the concentration, c, vs. radius, r, profile 
corresponds to a different equilibrium between monomers and Apo A-I complexes. 
Quantitative analysis is possible by calculating both the total Apo A-I concentration at a 
given radius r and the slope of the ln(c) vs. r2 curve at the same position. We determined 
local slopes of the ln(c) vs. r2 function by linearization of 8-10 consecutive data points, 
computing the slope of this linearized interval, and then shifting the interval to the next 
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data point. Figure 3B shows the apparent molecular mass, Mapp, as a function of the 
corresponding total Apo A-I concentration. We assumed that monomeric and 
oligomeric Apo A-I molecules have the same specific optical absorption at 280 nm. 
Figure 3B summarizes data obtained for Apo A-I solutions at initial concentrations of 3, 
40, and 160 μM measured at 6 different rotor speeds between 4 krpm to 15 krpm. Data 
scatter is considerable but the semi-logarithmic plot clearly shows a horizontal lag 
phase up to ~3 μM where no association occurs and where Mapp is identical to the 
molecular mass of monomeric Apo A-I. Above 3 μM Mapp increases sigmoidially. The 
solid line in Fig. 3B corresponds to the best fit using the cooperative model with Ka = 
3.5 × 105 M-1, n = 8, and σ = 0.003. Calorimetric measurements yielded Ka = 5.6 × 105 
M-1at 20 °C (represented by the dahsed line in Fig. 3B) indicating a good agreement 
between AUC and ITC. The nucleation parameter σ determines the length of the 
monomeric lag phase as well as the steepness of the transition curve.  
Figure 3C compares recombinant Apo A-I with Apo A-I purified from blood 
serum. It shows the degree of dissociation, α, as determined by AUC measurements at 
20 °C and 37 °C. 
 
Figure 3 
 
The data allow two conclusions. (i) Recombinant and serum-derived Apo A-I yield 
identical results within experimental error. (ii) The AUC data can be described 
quantitatively by the cooperative association model as displayed by the solid lines in 
Fig. 3C. At 37 °C the simulation yielded Ka = 4 × 105 M-1, σ = 0.003, n = 8 which 
agrees perfectly with the ITC data. At 20 °C the AUC data predicted Ka = 8 × 105 M-1 
which was slightly higher than expected on the basis of ITC measurements.  
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Differential scanning calorimetry (DSC) analysis of Apo A-I unfolding. The 
thermodynamics of Apo A-I unfolding was quantified by measuring dilute solutions of 
Apo A-I with differential scanning calorimetry. Fig. 4 shows the melting curves for Apo 
A-I concentrations from 0.5 to 4.5 mg/mL. The maximum of the molar heat capacity 
occurred at T0 = 52.6 °C for all three samples and was independent of protein 
concentration. The heat of transition, UNH∆ , was 422 kJ/mol (101 kcal/mol) and was 
also independent of the protein concentration, at least at 70.9 µM and 160 µM as the 
DSC scans were superimposable within experimental error. DSC scans were fully 
reversible if heating did not exceed 75 °C. Previous work on Apo A-I yielded DSC 
maxima between 57 and 63 °C and melting enthalpies between 58 to 200 kcal/mol [44, 
45, 66]. The differences may be caused by differences in protein preparations and salt 
conditions and also by neglecting the difference between initial and final Cp values. (In 
differential scanning calorimetry the sharpness of a transition is an indicator of the 
purity of the substance, the homogeneity of the probe, and the cooperativity of the 
transition. The recombinant Apo A-1 (with 2 additional C- terminal glycines) used here 
yielded the sharpest transition compared to all published DSC data on Apo A-I. A 
survey of DSC data on Apo A-I of different origin reveals a complex situation. 
Unfolding curves composed of three consecutive non-two state transitions [44, 45], two 
consecutive two-state transitions [66] or just one broad transition [51] were reported. 
Likewise, the unfolding enthalpy U 0NH∆  was 200 kcal/mol [44], 48 kcal/mol ([45], 
main peak), 84 kcal/mol [66], and estimated 200 kcal/mol [51]. The width of the 
melting curve at half-height was 14.3 °C in the present measurements, but ranged from 
14 °C ([45], main peak) over 20 °C [66], 22 °C [45] to 25 °C [51]. In the latter case [51] 
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the MALDI mass of the recombinant wild-type Apo A-1 is given as 29798 Da which is 
1719 Da (ca. 14 amino acids) larger than the authentic human Apo A-1. This could 
explain the differences observed in association behavior and differential scanning 
calorimetry between the present study and reference [51].) 
As Apo A-I unfolding was independent of protein concentration above 17 μM, the 
association process described in the previous section did not influence unfolding. This is 
discussed below in the context of a quantitative comparison of the two different 
equilibria.  
 
Figure 4 
 
A general problem in evaluating DSC thermograms is the definition of the 
baseline [67]. In the present studies the baseline was defined by the linear part of the 
calorimetric scan at low temperature and was extrapolated beyond the main transition as 
shown in detail in Fig. 5. This appeared to be justified as it led to constant Cp values 
before and after the transition. The difference between the two linear parts is the molar 
heat capacity change UN pC∆  = 5.0 kJ/molK (1.2 kcal/molK). A change in 
U
N pC∆  was not 
reported in the earlier DSC experiments [44, 45, 51, 66]. However UN pC∆  changes of 
several kJ/molK are found for other proteins (e.g. T4 Lysozyme, 164 aa, UN pC∆  = 5.1 
kJ/molK [68], human growth hormone, 192 aa, UN pC∆  = 8 kJ/molK [69].  
 
Figure 5 
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Knowledge of UN pC∆ provides insight into the molecular nature of Apo A-I 
unfolding. At low temperatures (T ≤ 20 °C) amide hydrogens are well protected by 
hydrogen bonds in the native protein structure. This is true whether the site in question 
is deeply buried or at the solvent-exposed surface [70]. Hydrogen-deuterium exchange 
was thus used to determine the α-helical segments of Apo A-I [70]. Thermal unfolding 
of Apo A-I increases the molecular fluctuations and H-bonds are transiently broken and 
brought in contact with solvent. While the increase in heat capacity is generally 
assigned to the exposure of apolar groups, a systematic study on cyclic peptides led to 
the conclusion: "The large apolar contribution suggests that a liquid hydrocarbon model 
of the hydrophobic effect does not accurately represent the apolar contribution to ΔH0 
of denaturation. Rather, significant enthalpic stabilizing contributions are found to arise 
from peptide groups (hydrogen bonding)" [71].  The heat capacity change upon water 
exposure of a single amide group has been estimated as UN pC∆  = 60 ± 6 Jmol-1K-1 [71]. 
The increase of UN pC∆  = 5.0 ± 0.5 kJ mol-1K-1 (1.22 kcal/molK) observed for Apo A-I 
could thus be caused by the exposure of about 83 amino acids, in agreement with the 
CD spectroscopy results to be discussed below.  
Figure 5 shows the temperature-dependence of the heat capacity and compares the 
experimental data with the predictions of cooperative model (fig. 5A) and the N  U 
two-state model (fig. 5B). An improved fit of figure 5B could be obtained by 
superimposing several N  U two-state transitions. 2 or 3 N  U two-state transitions 
were combined to simulate previous experimental DSC data as discussed above. The 
increase in the molar heat capacity between the fully folded and the unfolded protein 
was not considered in these earlier analyses.  
 
2. Thermodynamics of protein self-association and unfolding 
33 | P a g e  
 
 CD spectroscopy analysis of thermal Apo A-I unfolding. The structural changes 
associated with thermal unfolding were investigated with CD spectroscopy. Figure 6A 
depicts CD spectra of Apo A-I in buffer measured in 10 °C steps between 25 °C and 
85 °C. After heating to 85 °C and cooling to 25 °C the CD spectrum was virtually 
identical to the starting spectrum illustrating the reversibility of thermal unfolding. 
Inspection of figure 6A reveals spectral shapes characteristic of a predominantly α-
helical structure. However, a continuous loss of α-helix structure occurs with increasing 
temperature. 
 
Figure 6 
 
The quantitative evaluation of the α-helix fraction, fh, is possible with 
fh = (Θ222 + 3000) / (-39000) (31) 
 
where Θ222 is the molar ellipticity per residue at λ = 222 nm. The α-helix content 
evaluated by equation (31) decreases from fh = 45% at 25 °C to 18% at 85 °C, 
consistent with earlier observations [44-46, 48, 72]. Surprisingly, the loss of α-helix is 
compensated mainly by an increase in β-structure and not by random coil elements. 
This follows from simulations of the CD spectra in the range of 190-240 nm yielding 
the fractions of the main structural elements as shown in figure 6B. (Two different 
algorithms (cf. Materials and Methods) were applied and produced almost identical 
results.) The α-helix content is found to be higher than estimated with eq. (31). It is 
constant at fh ~ 50% - 54% below 45 °C and decreases to fh = 21% at 85 °C. The loss in 
α-helix-fraction upon heating is Δfh = 33%. At the same time the β-structure 
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contribution rises from 26% to 50% which has escaped notice in previous studies. The 
percentage of random coil segments increases modestly from 19% to 28%. The CD 
spectral simulations show that (i) the melting of Apo A-I is a multi-state process and (ii) 
the spectroscopic change of Δfh = 33% corresponds to the loss of (243 + 2) × 0.33 = 81 
helical segments. This result is in excellent agreement with the thermodynamic analysis 
given above (i.e. 83 helical segments) based on the change of the molar heat capacity 
U
N pC∆ . The solid line through the α-helix data is the prediction of the Zimm-Bragg 
model. 
Hydrogen bond enthalpy in a β-structure is much lower than that in an α-helix. 
For the membrane-binding peptide (KIGAKI)3, composed of 18 amino acids, hβ is 0.96 
kJ/mol (0.26 kcal/mol) for breaking a hydrogen bond in long stretches (n ≥ 18) of β-
structure [73]. For shorter arrays of β-structure, hβ can be 0 kJ/mol or be even slightly 
negative [74]. Thus from a thermodynamic point of view the α-helix  β-structure 
transition can be similar or identical to the α-helix  random coil transition, and β- and 
random coil-elements will be considered as thermodynamically equivalent in the present 
context. Significant differences between the enthalpies of β- and rc-segment formation 
should be reflected in the parameters of the Zimm-Bragg theory. However, for Apo A-I, 
and other proteins which we investigated, the enthalpy of helix disruption (h-value used 
in eq. (6)) was always in the range of 800 cal/mol to 1300 cal/mol.  
As an aside it should be noted that a plot of the λ = 222 nm ellipticity versus 
temperature (data of figure 6A) has its midpoint at 61 °C which is 8 °C higher than T0 
of the caloric transition. The discrepancy between CD spectroscopy and DSC is also 
obvious from inspection of figure 6B. CD spectroscopy monitors changes of the 
secondary structure only, while DSC includes also the melting of the tertiary structure.  
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Discussion 
The present analysis is of general relevance for the understanding of the 
thermodynamic behavior of oligomeric systems. Our experimental and theoretical 
results shed light on two different problems, that is, the thermodynamics of (i) unfolding 
an α-helical protein and (ii) the temperature- and concentration-dependence of a 
monomer  oligomer equilibrium. Cooperativity was found to play an essential role in 
both processes. The Zimm-Bragg theory was introduced as an alternative to the classical 
N  U two-state model for a consistent analysis of calorimetric and spectroscopic data 
on Apo A-I unfolding. The isodesmic self-association model was employed to describe 
the oligomerization of Apo A-I. The free energy for the addition of a monomer to any 
oligomer was assumed to be constant but the initial dimerization was less favorable by 
the nucleation factor σ, introducing cooperativity. Maximum self-association occurred 
at 21 °C whereas the mid-point of unfolding was at 52.6 °C. The measured heat of 
unfolding was ca. 100 kcal/mol and by a factor 5-10 larger than the heat of self-
association. The unfolding enthalpy was independent of concentration up to 160 μM. In 
the following we compare the temperature course of unfolding with that of Apo A-I 
dissociation. We provide a model calculation for the temperature- and concentration-
depencence of 0pC  for a cooperative monomer  oligomer equilibrium. 
 
Thermodynamics of Apo A-I unfolding. Crystal structure [42] and protein 
sequence analysis [75] predict that the Apo A-I region between residues 44 and 241 is 
largely α-helical. The 2.2 Å crystal structure of C-terminal truncated Apo A-I (184 N-
terminal residues) reveals an approximate half-circle (80% helix) with the N-terminal 
2. Thermodynamics of protein self-association and unfolding 
36 | P a g e  
 
arranged in a loose bundle composed of four helices and an extended segment [42]. 
Unfolding of Apo A-I corresponds essentially to a disruption of α-helical regions and, to 
a minor extent, to the unfolding of the four-helix tertiary structure. As a new approach 
we describe the Apo A-I unfolding with the cooperative Zimm-Bragg theory. Figure 5A 
compares the experimental DSC scan with the prediction of the cooperative h  β, rc 
model. The parameters used were: H-bond stability h = 4.6 kJ/mol (1100 cal/mol), 
nucleation factor σ = 4.4 × 10-5, T1 = 339.7 °K and n = 85. The predicted mid-point 
temperature for this short α-helix was T0 = 325.6 °K, in agreement with the maximum 
of the measured pC  vs. T curve. Attempts to simulate the DSC curves with distinctly 
shorter chain lengths than n = 85 were unsuccessful as the width of the transition region 
became too broad. Hydrogen exchange experiments indicate long stretches of α-helix 
secondary structure between Apo A-1 residues 7 and 115 with a total of 95 α-helical 
residues [70]. It is the unfolding of this region which is most likely monitored in the 
DSC experiment. A second α-helical region of 32 residues is found at positions 147 – 
178 [70]. As Apo A-1 has an α-helical content of 18% even at 85 °C (corresponding to 
ca. 40 residues) this α-helix could account for the residual ellipticity observed in CD- 
spectroscopy (cf. figure 6). 
The enthalpy per hydrogen bond can also be derived directly from the transition 
enthalpy without resorting to a particular model. As the unfolding enthalpy is UNH∆ = 
422 kJ/mol (101 kcal/mol) and as CD spectroscopy suggests that ~85 segments are 
involved in the transition, an α-helix stability of h = 422/85 ≈ 5.0 kJ/mol (1188 cal/mol) 
can be estimated, in good agreement with the value used in Zimm-Bragg theory.  
Figure 5B displays the related calculations with the N  U model. The 
experimental transition temperature was T0 = 325.6 K, as defined by the maximum of 
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the Cp curve. The unfolding enthalpy UNH∆  required for an optimum fit was 285 kJ/mol 
(68.2 kcal/mol). This value is much lower than the experimental result of 422 kJ/mol 
(101 kcal/mol). The N  U model also predicts a sharper transition than observed 
experimentally.  
The theoretical transition enthalpy characterizing the two-state N  U equilibrium 
is often denoted with van't Hoff enthalpy, ΔHvH, and derived from CD-measurements. 
For Apo A-I ΔHvH is much smaller than the calorimetric transition enthalpy, U 0NH∆ , 
and the ratio U 0vH NH / H 1∆ ∆ <  is considered to reflect the low cooperativity of the Apo 
A-I unfolding [44, 45, 66]. In contrast, a high cooperativity index ncoop = 7.8 was 
defined by applying the Hill equation to describe the sigmoidicity of the thermal 
denaturation curve [46]. The Zimm-Bragg theory finally describes cooperativity in 
terms of the steepness of the transition curve. The smaller the nucleation parameter σ 
and the larger the number of hydrogen bonds to be broken, the more cooperative is the 
transition and the steeper the transition curve. In terms of the Zimm-Bragg theory Apo 
A-I unfolding is a highly cooperative process.  
 
Thermodynamics of Apo A-I self-association and monomer-oligomer 
probabilities. Both AUC and ITC demonstrate that self-association of Apo A-I is a 
concentration-dependent process. Fig. 3B indicated that Apo A-I is monomeric below 
~3 μM and self-associates at higher concentrations. The cooperative association model 
with n = 8 and σ = 0.003 gave the best fit to both the ITC and AUC data. Knowledge of 
Ka as deduced from the dissociation isotherm permits the calculation of the free energy, 
0
aG∆ , and entropy 
0
aT S∆  (see Table 1). At room temperature the enthalpy of 
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association, 0aH∆ , is close to zero while the Gibbs free energy, 
0
aG∆ , is large and 
negative. This means that the entropy of association is large and positive and is the 
driving force for the association at temperatures below 20 °C. As the temperature 
increases, the reaction becomes exothermic and the contribution of entropy gradually 
decreases.  
The Apo A-I solution contains states of oligomerization 1, 2, ..,j. The probability 
of their occurrence can be calculated with the partition function Q. If pj is defined as the 
probability of j-mers in solution, i.e. the number of oligomers of size j divided by the 
total number of species in solution, then  
j
j
j
j
n
p
n
=
∑
 (32) 
 
For the cooperative model one finds 
p1 = Q-1 and ( ) j 1j a Ap K c / Q
−= σ  (33) 
 
Figure 7 provides a comparison of the fraction of monomers, p1, and octamers, p8, 
plotted vs. the total monomer concentration 0Ac  (maximum association number n = 8). 
Also  
 
Figure 7 
 
included are the degree of dissociation 0A Ac / cα =  and the experimental results for α 
obtained from the titration experiment shown in Fig. 1.  
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 Figure 7 reveals that the degree of dissociation, α, decreases faster than the 
monomer probability, p1. This follows because only one A8 molecule is generated when 
eight monomers associate, and the loss of monomers thus proceeds faster than the 
growth in the number of oligomers. Monomers and octamers are the predominant 
species in solution. However, the sum p1 + p8  goes through a minimum at a total Apo 
A-I concentration of ca. 6.7 × 10-4 M, with monomers and octamers accounting for only 
70% of the total species. This indicates that the solution contains additional 
intermediates.  
Earlier studies on Apo A-I self-association primarily relied on AUC 
measurements where a monomer-dimer-tetramer-octamer model was assumed [61, 62]. 
Separate association constants were defined for each association step. However, when 
applied to the present ITC data, this model did not provide satisfactory quantitative 
results. 
Apo A-I association has also been reported in terms of an 'apparent molecular 
weight' [65]. Mapp can be calculated in the present notation as  
n
A
app j W
j 1
M jp M
=
= ⋅∑  (34) 
 
A
WM  is the molecular mass of the Apo A-I monomer. Eq. (34) was used to simulate the 
data in Fig. 3B. Excellent agreement with the ITC experiments was obtained. 
 We have also analyzed previous Mapp results for Apo A-I with the cooperative model 
discussed above. For example, simulating the Mapp data given in reference [65] (figure 
2, 0.13 M KCl) with the cooperative model required σ = 0.003 and K = 6 × 105 M-1 for 
n = 8. These are exactly the values predicted by the present ITC experiments for the 
self-association at 20 °C. 
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Apo A-I unfolding vs. Apo A-I dissociation. Protein association and denaturation 
can be tightly connected processes as demonstrated for a 54 amino acid fragment of 
GCN4 [76]. Increasing the protein concentration by a factor of 100 in this example 
shifts the midpoint of the unfolding transition by about 20 °C towards higher 
temperatures. In contrast, Apo A-I unfolding was independent of the protein 
concentration (up to 160 μM). Self-association reached its maximum at 21 °C and 
decreased both at lower and higher temperatures, while Apo A-I unfolding had its 
maximum change in the heat capacity (midpoint of unfolding transition) at 52.6 °C. 
Considering a 160 μM (70.7µM) Apo A-I solution at 45 °C, which is the onset 
temperature of the unfolding reaction, the fraction of monomers is 6.5% (12.8%), while 
that of octamers is 59% (51%), referenced to total monomeric Apo A-I. Hence at the 
beginning of the unfolding process the solution is mainly composed of oligomers. We 
therefore calculated the contribution of Apo A-I dissociation to the molar heat capacity 
change by the following thought-experiment. We considered an Apo A-I solution where 
the Apo A-I molecules were locked in their native conformation at all temperatures. The 
change in the molar heat capacity was thus exclusively caused by the dissociation of 
Apo A-I complexes. Using eqs. (19), (20), and (22) the molar heat capacity change of 
the dissociation equilibrium was calculated and compared with that of protein 
unfolding. Figure 8 displays  
 
Figure 8 
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such calculations for three protein concentrations. As expected the heat capacity of the 
dissociation equilibrium depended on the total Apo A-I concentration, 0Ac . The 
maximum of the molar heat capacity shifted from 55 °C at 17 μM Apo A-I to 72 °C at 
160 μM while the width of the transition was reduced. The predicted molar heat 
capacity was 3.7 kJ/molK (1.98 kJ/molK) for 70 μM (160 μM) Apo A-I at 53 °C which 
was much smaller than the molar heat capacity at the Cp maximum of the unfolding 
reaction of 0pC = 24.6 kJ/molK. Figure 8 predicts that the dissociation of virtual, folded 
Apo A-I complexes should occur at temperatures higher than that of Apo A-I unfolding. 
An additional transition peak should appear in the Cp vs. T diagram. As this was not 
observed experimentally it is safe to conclude that Apo A-I unfolding and dissociation 
occur simultaneously. This is consistent with the observed concentration-independence 
of the unfolding transition. As the heat capacity change of the dissociation reaction 
makes only a small contribution (figure 8), the calorimetric UNH∆  is dominated by the 
unfolding of secondary structural elements.  
 
Concluding Remarks. We showed that protein self-association can be readily 
analyzed by the method of binding partition functions. This approach allowed 
comparison of different association models and provided analytic expressions to 
analyze experimental AUC and ITC results. The thermodynamic parameters of Apo A-I 
self-association are quite similar to those of other, more specific, protein-protein 
interactions. For example, the interaction of stathmin, a 17 kDa protein, with tubulin 
(~55 kDa) was investigated with ITC [77]. Similar to the present results the binding 
constants of the binary complex were 106 - 107 M-1. Likewise, ΔH0 was also 
endothermic at low temperatures and attained zero values at 28 °C. The fact that some 
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biological systems have very small reaction enthalpies at ambient temperature 
demonstrates that they minimize the temperature sensitivity of the corresponding 
chemical equilibria, leading to temperature-independent concentrations of the involved 
proteins. Another example supporting this conclusion is apolipoprotein C-1 showing a 
maximum of self-association at room temperature which is also reduced upon heating or 
cooling [78].  
We further showed that the cooperative Zimm-Bragg model provided an accurate 
description of Apo A-I unfolding and should be considered as an alternative to the 
common two-state N  U model, at least for proteins with a high α-helix content. For 
comparison, we analyzed experimental DSC results for a 22-kDa (N-terminal) fragment 
of Apo E2 which is about 50% α-helical at 20 °C ([79], Fig.1). An excellent fit of the 
DSC curve was obtained with h = 5.02 kJ/mol (1200 cal/mol) and σ = 3 × 10-5, 
parameters very similar to those of Apo A-I. As a second example we analyzed the 
calorimetric trace of a 50-residue peptide (figure 3 in reference [57]) with the Zimm-
Bragg model and again obtained excellent agreement with experimental values using h 
= 930 cal/mol and σ = 4 × 10-3. These results are consistent with a follow-up study of 
the same peptide with CD-spectroscopy resulting in h = 960 ± 20 cal/mol and σ = (2.9 ± 
0.3)× 10-3 [80]. Application of the N  U model completely failed for this 50-residue 
peptide.  
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Legends to figures 
 
Figure 1: Dissociation reaction of Apo A-I measured with isothermal titration 
calorimetry (ITC). 
(A) Heat flow. A 160 μM solution of Apo A-I in PBS buffer (138 mM NaCl, 10 
mM sodium phosphate, pH 7.4, 0.02 % NaN3) was injected at 2 μL aliquots into the 
calorimeter cell (Vcell = 0.2 mL) containing only buffer. The heat of reaction, δhi, arises 
from the dissociation reaction of Apo A-I oligomers as each injection corresponds to a 
ca. hundred-fold dilution of protein concentration. The measurement was made at 
40 °C. At room temperature the heat of dissociation is close to zero and the 
disassociation reaction is not detectable by ITC. 
(B) Integrated heats of reaction, δhi, as a function of injection number. The solid 
line shows the theoretical analysis based on the cooperative association model. 
Maximum association number n = 8, association constant Ka (40 °C) = 3.5 × 105 M-1, σ 
= 0.003, measured heat of dissociation ΔH = 49.1 kJ/mol (11.74 kcal/mol). The 
corrected heat of dissociation was 51.3 kJ/mol (12.3 kcal/mol) as the starting solution 
contained 4.4% monomers. 
 
Figure 2: Thermodynamic parameters of Apo A-I self-association. 
(A) Enthalpy, 0aH∆ , of Apo A-I self-association as determined with isothermal 
titration calorimetry.  
(B) Temperature-dependence of the association constant Ka. Ka was calculated by 
fitting the dilution isotherms of the calorimetric titration experiments with the 
cooperative association model using n = 8 and σ = 0.003. The solid line predicts the 
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temperature dependence of Ka by combining the van't Hoff equation with the 
temperature-dependent 0aH∆  of fig. 2A.   
 
Figure 3: Apo A-I self-association measured with analytical ultracentrifugation (AUC). 
(A) Sedimentation equilibrium experiments. Apo A-I at a concentration of 160 
μM in PBS buffer was centrifuged for 96 hrs at 6 krpm (black line) , 8 krpm (red) and 
10 krpm (blue) at 20 0C.   
(B) Apparent molecular mass, Mapp, as a function of total Apo A-I concentration. 
3 concentrations were simultaneously measured. 3 μM (blue data points, cuvette size 12 
mm); 40 μM (green data points, cuvette size 3 mm); 160 μM (red data points, cuvette 
size 1.4 mm). Measurements at 6 krpm (■), 8 krpm (▲), 10 krpm (♦), 12 krpm (●) and 
15 krpm (). Analyses were limited to a maximum optical density of OD = 2. The solid  
line was calculated with the cooperative association model using n = 8, σ = 0.003, Ka = 
3.5 × 105 M-1. The dashed line corresponds to Ka = 5.6 × 105 M-1 predicted by ITC at 
20 °C. 
(C) Degree of dissociation, α, as a function of total protein concentration. 
Recombinant Apo A-I (■) is compared with serum-purified Apo A-I (♦). Measurements 
were made at 20 °C (blue points) and 37 °C (red points). The solid lines are the 
predictions of the cooperative association model with n = 8, σ = 0.003, and Ka = 4.0 × 
105 M-1 (37 °C, red line) or Ka = 8 × 105 M-1 (20 °C, blue line).  
 
Figure 4: Differential scanning calorimetry (DSC) of recombinant Apo A-I. 
Apo A-I unfolding reaction measured at 17.7, 70.9 and 160 μM. The transition 
maximum occurred at 52 - 53 °C and was concentration independent. The normalized 
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DSC scans at 70.9 and 160 μM are superimposable. The heating rate was 1 °C/min. All 
measurements were made in buffer (10 mM sodium phosphate, 138 mM NaCl, pH 7.4, 
0.02% NaN3). The measurement at 17.7 μM was at the limit of sensitivity and could not 
be used for an evaluation of unfolding enthalpy. 
 
Figure 5: Interpretation of Apo A-I thermal unfolding comparing two models. 
The experimental result (black line) is the DSC scan of a 160 μM Apo A-I 
solution in PBS buffer measured at a heating rate of 1 °C/min. (A) Zimm-Bragg model 
(red line) using σ = 4.4 × 10-5, h = 1100 cal/mol, n = 85, U 0N pC∆ =  5.0 kJ/mol. Predicted 
T0 = 325.6 K. The midpoint of the h → β, rc transition of an infinitely long α-helix is at 
T1 = 339.7 K. 
(B) N  U 2 two-state model (red line) using UNH∆  = 285 kJ/mol (68.2 kcal/mol), 
U 0
N pC∆ =  5.0 kJ/mol, and T0 = 325.6 K 
 
Figure 6: Thermal unfolding analysis of recombinant Apo A-I by CD spectroscopy. 
(A) Far-UV-CD spectra of Apo A-I for temperatures between 25 °C (black line) 
to 85 °C (blue line) recorded at 10 °C steps. Apo A-I concentration was 0.5 mg/mL 
(17.7 μM) in buffer (100 mM NaF, 10 mM sodium phosphate, pH 7.4). Measurements 
at a lower concentration of 0.1 mg/mL (3.6 μM) yielded similar spectra in the range of 
25 - 65 °C.  
(B) Deconvolution of the CD spectra in terms of 3 structural elements. (■) α-
helix, (●) β-sheet, (♦) random coil. The β-turn element is not shown as it was always 
close to zero.  Figure 6 demonstrates that the loss in α-helix content is mostly 
compensated by an increase in β-structure. The solid line is the predicted α-helix 
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content as calculated with the Zimm-Bragg theory using a nucleation parameter σ = 4.4 
× 10-5, a hydrogen bond enthalpy per helix residue of h = 1100 cal/mol, and n =85 as 
deduced from the DSC and CD unfolding experiments.  
 
Figure 7: Self-association of Apo A-I. Probabilities of monomers and octamers. 
(■) Apo A-I degree of dissociation, α, as derived from the ITC experiment shown 
in figure 1. Solid lines: predicted probabilities (mole fractions) of monomers, p1, and 
octamers, p8, as a function of the total protein monomer concentration, 0Ac , at 40°C . 
Calculations with the cooperative association model σ = 0.003, Ka = 3.5 × 105 M-1, 
maximum association number n = 8.  
 
Figure 8: Computed DSC scans for a solution containing virtual Apo A-I oligomers 
which dissociate but remain folded. 
Three different protein concentrations were compared. The melting curves were 
calculated with the cooperative association model. The temperature dependence of the 
association constant was ΔHa (kcal/mol) = -0.659 (T-273) + 13.288 and the association 
constant at 273 K was 3.5 × 105 M-1. The temperature dependence of Ka was identical to 
that in figure 5B. The maximum association number is n = 8 and the cooperativity 
parameter σ = 0.003. Blue line: 17.7 μM, red line 70.7 μM, magenta line 160 μM. 
A) Molar heat capacity change, 0pC . The maximum of the dissociation reaction 
shifts to higher temperatures with increasing protein concentration. B) Degree of 
dissociation, α 
 
2. Thermodynamics of protein self-association and unfolding 
47 | P a g e  
 
Table 1 
Thermodynamic parameters of Apo A-I self-association equilibrium calculated with the 
cooperative association model 
 
 Maximum association number N = 8 
Tem
p 
cApo A-I ΔH a) 0aH∆
b) σ Ka 0aG∆  
0
aT S∆  
C μM kcal/mol kcal/mol  M-1 kcal/mol kcal/mol 
5 160 -7.7 8.14 0.003 2.8E+05 -6.90 15.04 
5 160 -8.51 9.03 0.003 2.6E+05 -6.86 15.89 
10 160 -6.95 7.19 0.003 4.8E+05 -7.33 14.52 
10 160 -7.03 7.31 0.003 4.0E+05 -7.23 14.55 
35 160 7.34 -7.59 0.003 4.9E+05 -7.99 0.40 
40 80 9.22 -10.1 0.003 3.3E+05 -7.87 -2.20 
40 160 11.74 -12.3 0.003 3.5E+05 -7.91 -4.37 
45 160 18.5 -19.8 0.003 2.4E+05 -7.80 -11.99 
 
a) ΔH = heat of dissociation as measured in the calorimetric experiment. While the 
precision of an individual calorimetric measurement is high (± 0.2 kcal/mol) the 
reproducibility is determined by different factors and is of the order of ± 1.3 kcal/mol.  
b) 0aH∆  is the enthalpy of protein association, 
0
aH∆  = -ΔH/(1-α), where α is the fraction 
of monomers in the starting solution.  
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Appendix: Dynamic light scattering and analytical 
ultracentrifugation with Apo A-1 
 
Dynamic light scattering (DLS) 
 
To determine the size of Apo A-1 self-associates, dynamic light scattering (DLS) was 
performed in a Zetasizer Nano ZS (Malvern Instruments Ltd., Worcestershire, UK) 
device. Light scattering was recorded and analyzed in terms of an autocorrelation 
function (Chapter 2: Materials and Methods), which was translated into a size 
distribution by software provided from Malvern instruments. The size distribution by 
intensity was converted into a size distribution by volume via software. 
 
Table 1: Comparison of DLS measurements with Apo A-1 at a concentration of 7 and 160 µM 
in PBS buffer. 
Sample 160 µM 7 µM 
Attenuator 9 11 
Measurement Position / mm 4.65 4.65 
Temperature / °C 19.9 20 
Average PdI 0.190 0.207 
 
Apo A-1 solutions in PBS (+ 0.02 % NaN3) at a concentration of 7 and 160 µM were 
measured in the DLS device. 
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The size distribution by volume is shown in Figure 1. Measurements at concentrations 
of 7 µM were at the border of sensitivity of the device. The diameter of Apo A-1 
oligomers was calculated to be the same for both (11 nm) concentrations contradicting 
the results obtained by AUC and ITC where concentration dependent oligomerization 
was found (Chapter 3: Published article). There, Apo A-1 was found to be mainly 
monomeric at 7 µM and oligomeric (8 Apos) at a concentration of 160 µM. 
The attenuator of the DLS device has already reached its highest value of 11 for 
measurement at 7 µM Apo A-1 (Figure 1 and Table 1). Thus the question whether a 
solution of 7 µM Apo A-1 has already reached the threshold of sensitivity is debatable. 
On the other hand, the increased viscosity at 160 µM could lead to non-ideal effects that 
could have falsified the results.  
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Figure 1: Size distribution by volume of three identical DLS measurements with 7 µM (A) and 
160 µM (B) Apo A-1 in PBS buffer. 
 
Diameter calculation of an eight monomer self-associate 
 
On basis of the DLS data the diameter of a possible octamer was calculated: 
 
The molecular weight of a complex of six monomers is 
 
8 · 28'200 g/mol = 225'600 g/mol. 
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Mass 8 molecules: m = 3.7456 · 10-19 g 
 
Volume 8 molecules: V = 3.7456 · 10-19 g / 0.73 g/cm3 = 5.1310 · 10-19 cm3 
 
Radii: V = 4/3 πr3 = 5.1310 · 10-19 cm3  
 
r = 4.9663 · 10-7 cm = 4.69 nm 
 
Diameter: d = 9.93 nm 
 
The result of almost 10 nm is in a similar range as the resulting size of 11.5 nm (160 
µM) measured by DLS 
 
Analogous the number of monomers in one oligomer was calculated via the measured 
particle size. The calculation yielded 12 Apos per oligomer, which is in a similar range 
to the assumption of eight Apos derived by AUC and ITC measurements for highly 
concentrated samples, such as 160 µM. 
 
Analytical ultracentrifugation 
 
Additional measurements in a XL-I centrifuge (Beckman Coulter, Indianapolis, IN; 
Rotor: Ati50) were performed with Apo A-1 and alternative models were used to 
analyze the data. 
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Apo A-1-solutions (10.8 mg/ml) were dialysed (Visiking, MWT 14000 cutoff, 3 days, 4 
x 1:1000) against PBS buffer (+ 0.02 % NaN3). Subsequently the concentration was 
determined by UV-VIS spectroscopy. The buffer of the last dialysis bath was used to fill 
the reference compartments of the analytical ultracentrifuge cells. 
 
Experimental determination of υbar 
 
The specific partial volume, υbar which was used for analyzing AUC data in the 
published article (Chapter 3) was calculated to be 0.736 ml/g as a sum of the specific 
partial volume of each amino acid of Apo A-1. However, a calculated value can differ 
from the real υbar of a protein due to possible cavities and hydration effects of the 
macromolecule. When analyzing a sedimentation equilibrium run the resulting 
molecular mass is very sensitive to changes in the specific partial volume. Hence υbar 
was attempted to be found experimentally.  
Apo A-1 was dissolved in PBS buffer (+ 0.02 % NaN3) with different D2O 
concentrations in order to prepare buffers of different densities. The concentration of 
Apo A-1 (3.5 µM) was chosen to exhibit a sufficient absorption (A0 ≈ 0.15) in a 
centerpiece with 12 mm path length but at low enough protein concentration so that the 
solution contains only monomers. The sedimentation equilibrium was measured at 8, 
12, 15, 20, 25 und 30 krpm. The last five scans of measurements at 12, 15, 20 and 
25 krpm were averaged and analyzed as described in as follows. 
The concentration at a certain point in the cells a(r) is described by  
, ( ) ( )
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a0 is the initial absorbance at the beginning of the experiment. Mb is the buoyant weight, 
ω is the angular velocity, R the ideal gas constant and T the temperature. r0 is the radius 
value of the sample-air interface (meniscus) and r is the radius, that is defined between 
the meniscus and the bottom of the cell. 
 
Transformation yields 
. 
 
The left side of the equation of each cell at each of the mentioned rotational velocities 
was fitted linearly against the radius r2-r02. 
The slope of the fit is 
. 
 
Referred to 
 
 
the buoyant weight Mb was fitted linearly against the density ρ of the corresponding 
D2O/H2O-PBS buffer. υbar is the specific partial volume. The slope of the fit is 
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and the axes intercept equates to the molecular mass Mw. The slope was divided by 
28.2 kDa in order to yield the specific partial volume υbar.  
 
Table 2: Results of analytical ultracentrifugation measurements with Apo A-1 in PBS and 
H2O/D2O solutions aiming to determine the specific partial volume υbar of the protein. 
velocity krpm 12 15 20 25 
intercept / Mw kDa 49.0 38.7 33.32 24.4 
υbar ml/g 1.3 1.0 0.9 0.6 
standard deviation ml/g 0.7 0.4 0.1 0.1 
R2 
 
0.40 0.58 0.93 0.90 
 
 
 
Figure 2: Calculated υbar of Apo A-1 is shown as a function of the velocities of the equilibria 
used for the calculation. The error of the results increased at lower velocities. υbar as a sum of 
the υbars of each amino acid is depicted as a blue horizontal line. 
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Table 2 and Figure 2 show the results of the calculations. υbar varies with the velocity at 
which equilibrium was attained. At lower velocities higher values of υbar as well as 
higher errors were observed. The increase of errors at lower velocities is probably due 
to the small slope of the concentration gradients in the AUC cells. Presumably this 
causes larger scattering of Mbs and thus larger errors. Furthermore a small deviation 
from equilibrium could play a role. However, this is unlikely as it was tested if 
equilibrium was attained by SedFit software. 
Apo A-1 was described to self-associate at concentrations above 0.1 mg/ml (≈ 3.5 µM). 
Self-association could alter the hydration of the protein yielding smaller values of υbar. 
Considerable higher concentrations than 3.5 µM of Apo A-1 were reached mainly in the 
region of the bottom of the cell, especially at higher velocities. This might lead to 
smaller values of υbar for measurements at high velocities compared to those at low 
velocities. On the other hand, with increasing velocities the molecular mass Mw, 
determined by intercept, decreased (Table 2).  
 
Sedimentation Velocity (SV) 
 
Performing the SV mode the sample is spun down to the bottom at relatively high 
(42 krpm) and constant radial velocity. The sedimentation is detected by means of 
optical systems and followed by acquiring scans every five minutes.  
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Table 3: Sedimentation coefficients of Apo A-1 in PBS buffer at different concentrations. 
Sedimentation coefficient distributions were obtained by SedFit software analysis. The main 
peaks are written in bold red, others are in blue, whereas very small peaks are written italic and 
black. 
 
Table 3 shows sedimentation constants at different protein concentrations derived by 
SedFit software analysis. If several peaks were observed, they are categorized into 
small, normal, and main peaks. The main peaks are plotted as a function of protein 
concentration in Figure 3. At concentrations above 0.28 mg/ml oligomers with a 
sedimentation coefficient of 4.6 · 10-13 s are mainly populated. However, the results 
suggest the existence of only two species with sedimentation coefficients S of  
S ≈ 2· 10-13 s and S ≈ 4.6 · 10-13 s except one outlier at 2.25 mg/ml with a small peak at  
S = 6.5 · 10-13 s. The presence of only two oligomeric states of Apo A-1 is contradicting 
the results obtained by ITC and AUC SE measurements, where oligomers of different 
detection concentration c 
 
sedimentation - coefficient S 
 
 
mg/ml 
 
10-13s 
 interference 0.09 1.9 4.6 
 absorbance 0.09 2 
  interference 0.28 2.1 4.6 
 absorbance 0.28 2.2 4.6 
 interference 0.57 1.8 4.6 
 absorbance 0.57 
 
4.8 
 interference 1.13 
 
4.8 
 interference 2.25 
 
4.6 6.5 
interference 9.72 
 
4.3 
 
2. Thermodynamics of protein self-association and unfolding 
70 | P a g e  
 
sizes were suggested. Calculation of the molecular weight from the sedimentation 
coefficients is difficult due to the lack of the frictional ratio of oligomers and the 
monomer. An approximate calculation of the molecular weight is shown as follows. 
 
The sedimentation coefficient S is defined as 
 
 
M is the molecular weight, υ is the specific partial volume, ρ is the density of the 
solvent, NA the Avogadro number, r is the radius and η is the viscosity of the solvent. 
 
Assuming the following parameters 
S = 4.6 · 10-13 s  η = 0.01 Ns/m2  ρ = 10-3 kg/m3   
d = 9.93 nm   vbar = 0.73 ml/g, 
 
in the above mentioned equation and solving for the molecular mass M yields 
M = 90.72 kDa. 
 
Divided by the mass of one Apo A-1 molecule results in n = 3 Apos per oligomer. The 
same calculation for the sedimentation coefficient of S = 2.0 · 10-13 s and a radius of an 
Apo A-1 monomer of r = 2.48 nm (calculated analog to the radius of an octamer, see 
below) yielded a molecular mass of 20.86 kDa. This is less than the molecular mass of 
one Apo A-1 molecule (28.2 kDa), suggesting, that the approximation underestimates 
the molecular weight of the species. Consequently, the number of Apos per oligomer n 
( )
ηπ
υρ
rN
MS
A 6
1−
=
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= 3 is less than suggested by Sedimentation equilibrium results in combination with ITC 
results (n = 8, as discussed in Chapter 3: Published article). However, the approximation 
indicated that Apo A-1 is oligomeric at least at concentrations beginning at 0.5 mg/ml.  
 
 
Figure 3: Apo A-1`s main sedimentation coefficients of a sedimentation velocity measurement 
is shown as a function of its concentration. The results suggest two different oligomeric states, 
the larger at higher concentrations. 
 
 
Sedimentation Equilibrium (SE) 
 
SE measurements were analyzed by calculating the apparent molecular mass of short 
intervals in the concentration gradient in the published article (Chapter 3). An 
alternative approach of analyzing this data was done by means of SedPhat software with 
different fitting models.  
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Figure 4 shows the concentration profile in a cell after sedimentation of the protein at 
42 krpm. The upper part shows the enlarged baseline. It is almost zero in the upper part 
of the cell, hence a baseline absorbance of zero was used for further analysis.  
 
 
Figure 4: Concentration profile of a 160 µM Apo A-1 sample in PBS buffer after 40 h at 42 
krpm in order to determine the baseline absorbance. The profile is enlarged in the upper part of 
the figure. 
In Figure 5 an equilibrium concentration gradient of a 160 µM sample is shown at 
8 krpm. A single species model was fitted to the data in SedPhat software. The fitted 
absorbance data and thus the concentration were smaller than the measured ones at 
lower radii and vice versa. Therefore the model seems not applicable, since it does not 
account for different oligomeric equilibriums in the concentration gradient. The root 
mean square deviation (rmsd) of 0.045 is significantly higher than deviations caused by 
the noise of the detection system (0.005). An apparent molecular mass of 114 kDa is the 
result of this model, corresponding to a tetramer. 
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Figure 5: SedPhat-analysis of an 8 krpm sedimentation equilibrium run with 160 µM Apo A-1 
in PBS buffer by means of a single species model. The concentration profile is shown in the 
upper part. The red vertical line is the meniscus of the solution, whereas the blue vertical line 
stands for the bottom of the cell. The model was fitted to the data in between the green vertical 
lines. The part below shows the deviation of the fit and the data in absorbance units. 
 
As an alternative a monomer-n-mer-model was chosen. Two species without 
intermediates were assumed in this model, a monomer and the highest associate n. n 
was set to be five in Figure 6. A global fit of a 160 µM Apo A-1 solution in equilibrium 
at 6 and 8 krpm is shown. A set of different n values was chosen, while the rmsd was 
used as criteria of the fit quality. The rmsd of the fits are shown in Figure 7 as a 
function of the number of the highest associate n. The best fit is attained with n = 5 
corresponding to a pentamer, but rmsd values of fits with n between 4 – 7 were on a 
similar level. 
2. Thermodynamics of protein self-association and unfolding 
74 | P a g e  
 
 
Figure 6: SedPhat analysis of 160 µM Apo A-1 (in PBS buffer) in equilibrium at 6 and 8 krpm. 
A monomer-n-mer model with n = 5 was used to fit to the data. The concentration profiles are 
shown in the upper part. The red vertical line is the meniscus of the solution, whereas the blue 
vertical line stands for the bottom of the cell. The model was fitted to the data in between the 
green vertical lines. The part below shows the deviations of the fits and the data in absorbance 
units. 
 
Figure 7: An AUC SE run with 160 µM Apo A-1 in PBS buffer was analyzed with a 
“monomer-n-mer” model in SedPhat software. A bar chart of the rmsd value of each fit with 
different n values is depicted. Fits between n = 4 – 7 show a similar low rmsd values indicating 
good quality of the fit. 
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3. Lipid binding of Apo A-1 mimetic peptides 
 
Introduction 
 
Atherosclerosis is a clinical syndrome affecting a large number of people worldwide. 
Low serum high-density lipoprotein (HDL) levels were identified as an independent risk 
factor of cardiovascular disease. HDL is one of the key players in reverse cholesterol 
transport (RCT). RCT is a multi-step process resulting in the net movement of 
cholesterol from peripheral tissues back to the liver via the plasma [1]. The liver can 
eliminate excess cholesterol by secreting cholesterol or bile acids into the bile. 
Apo A-1 is a 28 kDa protein consisting of 10 repeating sequence homologies. It is the 
main protein constitutent of HDL (70 % of protein in HDL) present in plasma at a 
concentration of ≈ 35 µM in mice and humans. 
Large parts of Apo A-1 are in an amphipathic α-helical secondary structure. 
Amphipathic helices, a common feature of apolipoproteins, are grouped into seven 
distinct classes: A, H, L,G, L, C and M [2]. They differ in charge, charge distribution 
and charge density. Class A amphipathic helices are described by zwitterionic, 
negatively charged residues at the center of the polar face and positively charged 
residues clustering in the polar-nonpolar interface (Figure 1). The α-helices in Apo A-1 
feature mainly a class A amphiphatic motif. This structural motif imparts hydrophilic 
and hydrophobic regions and is found in many biologically active peptides and proteins. 
The polar and nonpolar face is oriented along the long axis of the α-helix. This 
distribution of physico-chemical properties forms a structural complement to that of 
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phospholipids and facilitates the interaction of the two types of molecules [2]. The 
interaction of Apo A-1 related peptides with lipids in the aqueous environment was first 
described by Segrest et al. [3].  
 
Figure 1: Helical wheel presentation of the peptide 4F on 
http://cti.itc.virginia.edu/~cmg/Demo/wheel/wheelApp.html. Nonpolar residues are depicted in yellow, 
polar but uncharged are in green, acidic are in rose and basic residues are in blue. The closer the residues 
are to the beholder the bigger are the circles. The amphiphatic character of the peptide is visible by the 
seperation of the hydrophilic and charged residues on the upper side and the hydrophobic on the lower 
part of the scheme. The criteria of class A amphiphilic helices are fulfilled with negatively charged 
residues clustered at the center of the polar face of the helix and positively charged residues at the 
polar/nonpolar unterface. 
 
The amphipathic helix motif class A in Apo A-1 is responsible for lipid binding. Hence, 
a 18 amino acid long model peptide of the amphipathic class A motif was designed and 
designated 18A. The sequence DWLKAFYDKVAEKLKEAF of this peptide had no 
sequence homology to Apo A-1 and is not present in any of the naturally occurring 
proteins. Together with DMPG lipids, discoidal complexes were formed that showed 
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structural similarities to those of Apo A-1. The complexes mediated cellular cholesterol 
efflux in cell culture similar to complexes with Apo A-1 [4]. The lipoprotein particles 
were, analog to HDL, able to activate the lecithin-cholesterol acyltransferase (LCAT), 
an important protein of the RCT. These and many other properties caused the 
classification of 18A as Apo A-1 mimetic peptide. Refinement of the peptide design by 
addition of an acetyl group to the amino terminus and an amide to the carboxyl terminus 
yielded increased helicity of the peptide upon addition to lipids [5]. The blocking of the 
termini also increased the cholesterol efflux and LCAT activation efficiency 
significantly. Further detailed studies of the physical and chemical characteristics of 
class A amphipathic peptides revealed that the hydrophobic region determines the 
biological activity of the peptides. Hence exchange of nonpolar residues in 18A with 
phenylalanine generated new peptides with increased hydrophobicity and increased 
affinity to lipids. The new peptides were designated 3F, 4F, 5F, ... depending on the 
total number of phenylalanines in the 18A sequence [6]. 4F showed highest activity in 
arterial wall cell cultures and prevented lesions better than other 18A analogs when 
tested in animal models [7]. Tandem helical peptides are obtained by an interruption of 
the helical sequence with a proline residue. A molecule composed of two 18As bridged 
by a proline (designated 37pA) was also investigated with respect to its Apo A-1 
mimetic characteristics. 37pA exhibits greater lipid binding affinity and greater ability 
to promote cholesterol efflux from cultured cells [4, 8-10]. The best studied Apo A-1 
mimetic peptide however is 4F. 
Apo A-1 and its mimetic peptides were tested extensively in vivo. Administration of 
Apo A-1 and a mutant version Apo AMilano-1 resulted throughout all studies in healthful 
changes in terms of cardiovascular disease. The requirement of intravenous 
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administration and large amounts of the protein ruled out the approach for 
pharmacological application [11]. Therefore the hope lies in Apo A-1 mimetic peptides.  
The plasma concentration of D-4F, the D enantionmer of L-4F used in our studies, was 
measured to be maximal 130 nM after oral administration to mice and only 4 nM after a 
single oral dose in humans. 4F was found to improve arterial vascoreactivity [12] and to 
be antiatherogenic in diabetes [13]. The peptide also improved insulin resistance and 
reduced adiposity in male obese mice [14, 15].  
Clinical trials with 4F have not yet led to clear results. The peptide was always well 
tolerated but the therapeutic results were ambiguous. Improvements of clinical markers 
like LDL-induced monocyte chemotactic activity were achieved after oral 
administration with a single dose of D-4F [16]. Though, intravenous and subcutaneous 
administration of L-4F yielded no biomarker change of HDL function [17].  
Most of the work with Apo A-1 mimetic peptides was done in cell culture and in animal 
models. Doing so, cardio-protective effects of these peptides were proven empirically. 
However, in vivo consequences of different peptide designs are still not predictable. 
These peptides have high potential of improving cardiovascular disease but mechanistic 
understanding and a detailed insight into lipid binding is lacking. We therefore studied 
in detail the binding of 4F and partly 4F-Pro-4F (denoted P) to lipids. 
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Materials and Methods 
 
Materials 
 
The peptides 4F (Ac-DWFKAFYDKVAEKFKEAF-NH2) and P (Ac-
DWFKAFYDKVAEKFKEAFPDWFKAFYDKVAEKFKEAF-NH2) were obtained 
from PEPTIDE 2.0 Inc. (Chantily, USA). Phosphate buffered saline (PBS), consisting 
of 10 mM sodiumphosphate (Merck, Darmstadt, Germany) and 138 mM NaCl (Merck), 
dissolved in Nanopure water and charged with 0.02 % NaN3 (Sigma) at pH 7.4 (25 °C) 
was used to dissolve the peptides if not specified differently. Alternatively, a buffer 
(HEPES) consisting of 10 mM HEPES (Roth) without any salt was used with and 
without 10 % DMSO (Merck). Buffers were filtered through sterile 0.2 µM regenerated 
cellulose and PTFE filters (Nano). 
 
Methods 
 
a. Dynamic light scattering (DLS) 
 
Measurements were performed at 25 °C in a Zetasizer Nano ZS ZEN3600 (Malvern; 
Worcestershire, UK), equipped with a HeNe laser (633 nm) and a backscattering 
detector (scattering angle of 173°). Solutions (PBS + 0.02 % NaN3, pH 7.4; 10 mM 
HEPES, pH 7.4 ± 10 % DMSO) were filtered (PES; 0.22 µm; Millipore; Billerica, MA) 
and measured in rectangular cuvettes (1 cm). The intensity autocorrelation functions 
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were evaluated using a second-order cumulant analysis yielding the translational 
diffusion coefficient D. The mean hydrodynamic diameter (DH) was calculated from D 
by using the Stokes-Einstein equation. The size distributions were calculated from the 
diffusion coefficient distribution using the CONTIN routine, and the resulting intensity 
counts were volume-weighted [18].  
 
b. High sensitivity isothermal titration calorimetry (ITC) 
 
ITC was performed using either the ITC-200 or the VP titration calorimeter from 
Microcal (Northampton, MA). The cell volumes were 200 μL and 1.4 mL, respectively, 
and the injection volume varied between 2 μL and 10 μL. Solutions were degassed 
under vacuum for about 10 min. Usually the calorimeter cell contained the peptide 
solution and the lipid vesicles were in the injection syringe. The heat flow associated 
with lipid binding was integrated by the software provided with the instrument and 
analyzed with a multiside binding model [18-20]. 
 
c. Circular dichroism (CD) 
 
CD spectra were obtained with a CD spectrometer Chirascan (Applied Photophysics 
Ltd., Leatheread, UK) in the wavelength range of 180 nm - 260 nm using a total 
acquisition time of 10 min per spectrum. Measurements were done at 25 °C with 
peptide concentrations of 176 µM in 100 mM NaF, 10 mM sodium phosphate, pH 7.4 at 
25 °C. Quartz platelets with path lengths of d = 0.1 mm were used and a baseline with 
pure buffer was recorded and subtracted from the sample spectra. The CD-spectra were 
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simulated with the non-commercial software CDpro [21] based on reference spectra of 
43 proteins (data set # 1). 
 
d. Analytical ultracentrifugation (AUC) 
 
A Beckman XL-I ultracentrifuge (Beckman Coulter, Indianapolis, IN USA) with UV- 
and Interference detection was used. Peptide solutions were measured in PBS and 
HEPES buffer at concentrations between 100 and 200 µM. Sedimentation velocity (SV) 
measurements were done at 20 °C. Depending on the protein concentration, the center 
piece length was 3 or 12 mm. The rotational speeds in the SV runs were 3, 10 and l8 
krpm.  
 
e. Static light scattering 
 
Measurements were performed either in a black 96-well plate suitable for fluorescence 
measurements (Corning) in a Spectramax M2 (Molecular Device, Sunnyvale, CA USA) 
plate reader with a light source at 350 nm and detection at 360 nm or in a rectangular 
2 mm cuvette in a FP 6500 Spectrofluorometer (JASCO Co., Tokyo, Japan) with 
emission and detection at 360 nm. 
 
f. Tryptophan fluorescence 
 
Measurements were performed in a rectangular 5 mm cuvette in a FP 6500 
Spectrofluorometer (JASCO Co., Tokyo, Japan). Emission spectra between 300 – 450 
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nm were collected with excitation at 290 nm. The samples were mixed and incubated at 
room temperature for one hour, before measuring in the spectrometer. 
 
g. Preparation of Lipid Vesicles 
 
A defined amount of lipids in chloroform was first dried under a nitrogen stream and 
subsequently overnight in high vacuum. Typically, 1-3 mL of buffer (PBS + 0.02 % 
NaN3, pH 7.4 at 25 °C) were added to the lipids, and the suspension was rigorously 
vortexed. For preparation of small unilamellar vesicles (SUVs), the lipid suspension 
was kept in an ice bath and sonified under a constant nitrogen stream using a titanium 
tip ultrasonicator until the solution became transparent (40 min without cholesterol and 
60 min with Cholesterol). Titanium debris was removed by centrifugation (Eppendorf 
tabletop centrifuge, 10 min at 12 000 rpm). The lipid concentration was calculated on 
basis of the weight of the dried lipid. Large unilamellar vesicles (LUVs) were prepared 
by the extrusion method [22]. After the dried lipid had been vortexed with buffer, six 
freeze and thaw cycles were performed with the lipid suspension and extruded through 
polycarbonate filters (13 times through 100 nm filters). 
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Results 
 
Association behavior of peptides 4F and P 
 
Apolipoprotein A-1 was shown to self-associate [22-25]. At concentrations below 3 µM 
Apo A-1 is monomeric starting to oligomerize with increasing concentrations. The self-
association behavior of Apo A-1 is described in Chapter 3 with a model similar to those 
used to describe the micellization of detergents [26]. Since the amphipathic character of 
the helices in Apo A-1 are similar to those of Apo A-1 mimicking peptides 4F and P we 
investigated if these peptides also self-associate.  
 
Dynamic light scattering (DLS) 
 
Self-association of the peptide 4F was studied with DLS. Figure 2 compares the 
autocorrelation curves of a suspension of 100 nm phospholipid vesicles (lipid 
concentration = 1.85 mM, in orange) with a solution of peptide 4F (cpep = 100 µM, in 
blue). The curve describes the autocorrelation as a function of time. Autocorrelation is 
the degree of similarity of the fluctuations in scattering intensity which arise from 
Brownian motion of scattering particles. An initial scattering of a particle at the time t0 
is compared with subsequent measurements of scattering after additional times 
t0+t1(+t2+…). An autocorrelation value of 1 stands for perfect correlation and can only 
occur at time zero. Since the particle is diffusing out of the detection volume a 
sigmoidal decay of the autocorrelation is observed in a plot of the autocorrelation 
against the logarithm of the time. The time it takes to diffuse out of the detected volume 
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is determined by the diffusion coefficient D, which depends on the size of the particle. 
The measured diffusion coefficient of the phospholipid vesicles was D = 4.90·10-12 m2s-
1 calculated with the Stokes-Einstein equation. For the 100 nm vesicles shown in Figure 
2 the autocorrelation decreased to the half of the value after about 45 us. In this time the 
vesicles moves 21 nm. Small particles are diffusing very rapidly and large particles 
diffuse slowly. 
 
 
Figure 2: Autocorrelation of light scattered by particles in buffer is shown as a function of time. DLS 
measurements of 1.85 mM 100 nm POPC LUVs (orange line) and of 100 µM 4F peptide dissolved in 
PBS buffer (blue line) are depicted. LUVs yielded a typical sigmoidal shape of the autocorrelation curve 
in contrast to the peptide, which is too small to be investigated by DLS. 
 
In the experiment shown in Figure 2 the second measurement follows 0.5 us after the 
initial one. If a particle diffuses very fast, the detection limit of the device is reached. 
This threshold is reached for particles with diameter ≤ 4 nm. For such solutions the 
initial autocorrelation is less than 0.5. The autocorrelation curve of the peptide 4 F (blue 
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curve in Figure 2) does not show the typical sigmoidal shape and starts below 0.4. 
Assuming a specific partial volume vbar = 0.73 g/cm3 of the peptide, a hexamer would 
still be below the detection limit of the DLS device.  
 
Figure 3: DLS measurements with 4F at different peptide and DMSO concentrations. To simplify the 
graph, only the initial value of the autocorrelation curves is shown. Autocorrelation curves with 
significant aggregates would yield initial autocorrelation values of approximately 1. Except of two 
samples particles are too small to be investigated by DLS. 
 
Analogous to the peptide measurements shown in Figure 2 a set of different conditions 
were investigated. The peptides were dissolved in PBS buffer at five different 
concentrations. For each concentration five different DMSO concentrations were chosen 
in the range of 0 – 50 % resulting in a total of 25 different samples. In the following, 
only the autocorrelation at t = t0 (ACt0, as average of three measurements with the same 
sample) is shown in order to simplify the analysis. In Figure 3 the ACt0 is plotted 
against the concentration of the peptide. The figure indicates that 4F in the presence of 
DMSO exhibits ACt0 values below 0.4. In contrast, the two solutions without DMSO at 
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the two highest peptide concentrations (25 and 50 µM) show ACt0 values of ACt0 ≈ 0.8. 
These results suggest the absence of large self-associates under most conditions, except 
at the two highest peptide concentrations in solutions without DMSO. Particle sizes 
could not be calculated by the Zetasizer software due to poor autocorrelation curves and 
high polydispersity indices (PDI ≥ 0.3). A high PDI is an indicator of the presence of 
particles of different size. A solution exhibiting a PDI below 0.25 is considered to be 
monodisperse, values above 0.3 are considered to indicate polydisperse solutions. 
 
 
Static light scattering 
 
DLS measurements have certain limitations. The DLS result neither quantifies the 
amount of scattering particles nor differentiates between particles of different chemical 
nature if they have the same size. Thus, a perfect auto-correlation curve could be 
measured in a peptide solution free of any peptide associates but containing tiny 
impurities such as dust particles. To distinguish between real associates and tiny 
impurities in the peptide solution, static light scattering was performed in a fluorescence 
plate reader (Spectramax M2) at 350/360 nm. The scattering is shown in Figure 4 as a 
function of the concentration. The same mixtures as before were prepared. The graph 
indicates that there is a rather constant scattering intensity independent of the peptide 
concentration and that there are only small differences as a function of the DMSO 
concentration, expect for one solution of 25 µM 4F, 0 % DMSO. 
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Figure 4: Light scattering intensities of 4F in buffers with varying percentages of DMSO (v/v) are shown 
in dependence of five different peptide concentrations. The scattering intensities were not significantly 
dependent on peptide and DMSO concentrations.  
 
Analytical ultracentrifugation 
 
The peptide aggregation was further studied by analytical ultracentrifugation as it 
allows the measurement of higher concentrations than is possible with dynamic and 
static light scattering. 4F (200 µM) and P (100 µM) were dissolved in PBS buffer und 
spun at 10 krpm for 10 hours. The results are depicted in Figure 5 and Figure 6. The 
absorbance at 280 nm is plotted against the radius. The radius begins in the center of the 
rotor leading to values of about 6 - 7.5 cm in the area of the windows of the cell. The g-
forces due to rotation cause sedimentation of particles having a specific density greater 
than the solvent. On the other hand an increased concentration gradient yields an 
enlarged diffusion flow, described by Fick`s laws. These opposing processes come to 
equilibrium, as soon as the sedimentation flow compensates the diffusional flow. At a 
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given specific density large particles experience a large sedimentation rate and a small 
diffusional rate. Consequently large self-associates sediment at lower rotational 
velocities than small monomers. If a peptide is sedimented to the bottom of the AUC 
cell, it is no longer detectable. In case of 4F, integrating the absorbance from meniscus 
to bottom yielded the same value before and after the AUC run. This proves that the 
protein was not sedimented to the bottom of the cell and lead to the conclusion, that no 
big aggregates were formed. The experiment was repeated with 10 hours at 42 krpm, 
again with 200 µM 4F in the AUC and still no sedimentation and meniscus depletion 
was observed. 
Trying to dissolve 100 µM P in PBS buffer led to huge aggregates, which were visible 
even by eye. The solution with its aggregates was filled into AUC cells and spun at 3 
and 10 krpm for 8 hours and 5 hours, respectively (Figure 7). The absorbance of 
100 µM P at 280 nm the length of the centrifugation cell was constant 0.26 at the first as 
well as at the last scan but should be 1.37. This means that over 90 % of the peptide was 
sedimented to the cell bottom, while 10 % were kept in solution without any further 
tendency to aggregate and sediment. Therefore 4F was used in PBS buffer, while P was 
used in HEPES-buffer together with 10 % DMSO. 
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Figure 5: Analytical Ultracentrifugation scans of 200 µM 4F in PBS buffer at 10 krpm at the beginning of 
the measurement (blue line) and after 10 hours (red line). Analysis confirmed mass conservation of the 
peptide, meaning that all peptide is remained in solution. 
 
 
Figure 6: Analytical ultracentrifugation run with 200 µM 4F in PBS at 42 krpm after 10 hours. 
Sedimentation and meniscus depletion were not observed. 
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Figure 7: Analytical ultracentrifugation runs with 100 µM P at 3 and 10 krpm. The initial and the last scan 
after eigth hours at 3 krpm are depicted in blue, respectively in red. The last scan after 5 hours at 10 krpm 
is depicted in green. The detected concentration is about 10 µM and does not tend to sediment. This 
means that 90 % of the initial concentration is sedimented, which was visible even by eye. 
 
Isothermal Titration calorimetry (ITC) 
 
The self-association of Apo A-1 is described in Chapter 3. The dissociation reaction 
was measured by diluting a concentrated Apo A-1 solution (160 µM) in the ITC device 
and monitoring the heat changes.  
Similar ITC dilution experiments were performed to test if reversible associates are also 
present in 4F solutions (Figure 8). Concentrated solutions of 4F (200 µM) were injected 
into PBS buffer at different temperatures. The titration experiments showed a small 
endothermic reaction (≈ 1-3 kcal/mol), which could indicate dissociation. The  
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Figure 8: ITC measurements: Titration of 200 µM 4F into PBS buffer at 40 °C (first figure), 20°C (second 
figure) and 10 °C (third figure). Reversible self-associates of a highly concentrated peptide solution could 
dissociate by a dilution effect due to injection into pure buffer. The heat of reaction are slightly 
decreasing , exept of the measurement at 40 °C. This could be a sign of a dissociation reaction, which is 
not detectable at 40 °C either because there are no oligomers at this temperature, that could dissociate or 
because the enthalpy of dissociation has its zero crossing at 40 °C. 
heat peaks were almost constant at temperatures of 40 °C and decreased at lower 
temperatures. The dependency on temperature might be a sign of different 
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monomer/oligomer equilibrium with the existence of more oligomers at lower 
temperatures and vice versa. Another possibility could be that the enthalpy of 
dissociation is zero at about 40 °C.  
 
Binding of peptides 4F and P to lipid membranes 
 
Binding of peptides to lipid membranes was investigated mainly by means of ITC. 
However, ITC results do not give any information about detailed processes and the 
driving force of the observed reactions. Therefore ITC experiments were compared with 
several other methods to characterize the reaction in detail. Static and dynamic light 
scattering were used to investigate the influence of the peptides on the vesicle structure. 
Circular dichroism spectroscopy was performed to investigate secondary structural 
changes of the peptides induced by lipid binding. Tryptophan fluorescence was 
measured to get insight into the change of the environment of the tryptophans due to 
lipid binding. 
 
Static light scattering 
 
Static light scattering measurements were performed to distinguish between insertion of 
the peptides into vesicles or micellization of vesicles. In the first case the radius and the 
scattering of the particles would slightly rise, in the second case scattering would almost 
diminish due to dissolution of the 100 nm vesicles. Static light scattering measures the 
intensity of light, scattered by particles in the solution of the cuvette. The scattering 
intensity is proportional to the sixth power of the particles diameter. 
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Figure 9: Static light scattering of POPC LUVs (5 mM) titrated into peptide 4F (200 µM) after 15 h 
incubation. The scattering intensity of the mixtures is shown as a function of lipid-to-peptide ratios (black 
dots) together with a pure LUV suspension (5 mM, red line). The low detected scattering intensity in 
presence of 4F indicates micellization of vesicles by 4F even at a 1:10 peptide to lipid ratio. 
 
Samples prepared by titrating POPC LUVs (5 mM) into a 4F solution (200 µM) with an 
incubation period of 15 h at room temperature. Figure 9 shows light scattering of the 
samples in dependence of the lipid-to-peptide ratios. The scattering intensity of the 
mixtures (2-9 arbitrary units (AU), 0 - 1.43 mM POPC) up to lipid-to-peptide ratio ≈ 3 
is much lower than expected for intact 100 nm vesicles (590 AU, 5 mM POPC). The 
low scattering intensity shows that the lipid vesicles were dissolved upon peptide 
addition, even at lipid-to-peptide ratios of 10. The scattering intensity is also 
proportional to the number of particles (concentration). However, the ratio of the lipid 
concentrations of the measurement with pure LUVs and the highest lipid concentration 
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in the mixtures is 3.5 (1.43 mM vs. 5 mM POPC) and does not explain the difference of 
scattering intensity of factor 65 between those two measurements (9 AU vs. 590 AU). 
 
Tryptophan fluorescence 
 
Peptide 4F contains a single tryptophan, and the change of tryptophan fluorescence was 
measured as a function of the peptide-to-lipid ratio (Table 1). Simultaneously, the 
mixtures were measured with dynamic light scattering (DLS). 
Fluorescence studies with indol dissolved in varying mixtures of ethanol/cyclohexane 
showed strong a dependence of the emission spectra on the environment of the 
fluorophor.  
Depending on the environment, the maximum of the tryptophan emission when excited 
with UV light at λex = 280 - 300 nm is found between λmax = 308 – 350 nm [27]. The 
fluorescence maximum is at λmax = 350 nm for tryptophan in a hydrophilic environment 
like water but shifts to smaller wavelength by exposure to a hydrophobic environment 
like the interior of a membrane. Peptides, which are completely bound to lipid 
membranes showed a maximal fluorescence at λmax = 332 nm in many cases [28]. In 
apoazurin Pfl the tryptophan is located in a completely apolar environment in the 
interior of the protein, which leads to a blue-shifted (λmax = 308 nm) emission 
characteristic comparable to indole in cyclohexane [27]. Tryptophan acts as a reporter 
of the environment of the tryptophan side chain as the fluorescence emission maxima 
shift to smaller wavelength, e.g. when the peptide binds to lipids. Binding of proteins 
and peptides to lipid vesicles can be performed either qualitatively by detecting a 
blueshift or in detail by calculating a binding constant out of the experimental data.  
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In Figure 10 the fluorescence emission spectra of the samples (Table 1) are shown. The 
change of the emission maxima is depicted in Figure 11. The emission maxima shifted 
to smaller wavelength (λmax = 335 nm) with increasing lipid-to-peptide ratios. This 
indicates a binding of peptides to lipid membranes as eluded above. Assuming the 
formation of an α-helix of all residues, the helical wheel representation suggests the 
tryptophan to be located on the hydrophilic side, but near the interface of the 
amphiphilic plane, which is going through the long axis of the helix Figure 1. Hence, 
binding of the nonpolar side of the helix to lipid membranes would position this residue 
in a nonpolar environment. 
 
Table 1: Table of 4F and POPC lipid mixtures and resulting sizes used for tryptophan – fluorescence and 
dynamic light scattering measurements. Sizes and the polydispersity indices (PDI) were measured by 
DLS. Asterisks on the PDI values indicate bad quality of correlation diagrams, the sizes should be 
interpreted with caution in these cases. 
 
Sample Peptide POPC SUVs L-to-P ratio Fluor. max. Size by DLS PDI (DLS) 
No µM mM  nm nm 
 
       
1 100 0 0 349 - - 
2 100 0.25 2.5 339 10.8 0.47* 
3 100 0.5 5 337 26.8 0.63 
4 100 1 10 336 583.1 0.50* 
5 100 1.85 18.5 334.5 655.4 0.54* 
6 0 1.85 - - 35.0 0.21 
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Figure 10: Tryptophan fluorescence spectra of different 4F/lipid mixtures (see Table 1) excited at 290 nm. 
The peptide concentration was 100 µM 4F, except of sample 6, and the lipid-to-peptide ratio (R) is 
marked in the legend. The fluorescence maxima of the spectra are shifted to smaller wavelength with 
higher lipid-to-peptide ratios due to interaction of these molecules. 
 
 
Figure 11: The tryptophan fluorescence maxima of 4F (100 µM) at different lipid mixtures (see Table 1) 
are depicted. A blueshift of the emission maxima with increasing lipid concentration is significant. 
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Dynamic light scattering (DLS) 
 
Figure 12 shows autocorrelation curves of various lipid-to-peptide ratios (Table 1, same 
mixtures as used for Trp-fluorescence) by means of DLS measurements. The inflexion 
point of autocorrelation curves gives a hint of the particle size. The higher the x-value of 
the inflexion point the bigger are the particles. Table 1 contains volume weighted size 
distributions. The particle size of the SUVs (35 nm) decreased at small lipid-to-peptide 
ratios to 10.8 nm, but increased with increasing lipid-to-peptide ratios to 655.4 nm. This 
was also easily observed by eye, as the slightly turbid SUV suspension turned into a 
clear solution at a lipid-to-peptide ratio of 2.5, but got milky beginning at lipid-to-
peptide ratios of 10. 
In comparison to results obtained by static light scattering the particle size at a lipid-to-
peptide ratio of ten must be different. While static light scattering indicate very small 
particles like micelles, the size of the DLS measurement is calculated to be 583 nm. 
This discrepancy might be explained by different reaction conditions. In the static light 
scattering the concentration of 4F was 143 µM and LUVs were used, while dynamic 
light scattering was performed with 100 µM 4F and SUVs. 
 
3. Lipid binding of Apo A-1 mimetic peptides 
98 | P a g e  
 
 
Figure 12: Autocorrelation curves of 100 µM 4F and various POPC lipid concentrations (see Table 1) 
used for tryptophan fluorescence were also measured by DLS. The peptide concentration was 100 µM 4F, 
except for sample 6 (pure lipid), and the lipid-to-peptide ratio (R) is marked in the inset. The x-value of 
the inflexion point correlates with the size of particles in solution. The orange line is a measurement of 
the peptide without lipids. Small lipid concentrations decrease, whereas high concentrations increase the 
size of the particles at a constant peptide concentration of 100 µM 4F. 
 
Circular dichroism spectroscopy (CD) 
 
The secondary structure of the peptide 4F was checked with CD spectroscopy, without 
and with different amounts of POPC lipids (Table 2). In Figure 13 CD spectra at 
different lipid-to-peptide ratios are shown for 4F. Analysis of the spectra with three 
different algorithms of the software CDpro is depicted in Figure 14 as a function of the 
lipid concentration. Free peptide consisted mostly of α-helix (≈ 40 %), about 35 % β-
sheet&β-turn and 25 % of random coil structure. The α-helical part of the peptides 
increased with increasing lipid-to-peptide ratios at the expense of β-sheet&β-turn and 
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random coil fractions (Figure 14). The results suggest that binding of the peptide 4F to 
lipids induce a random coil and β-sheet&β-turn to α-helix transition. 
 
Table 2: Circular dichroism (CD) measurements with mixtures of the peptide 4F together with various 
POPC LUV concentrations. Chloride ions of the PBS buffer were exchanged by fluoride. 
 
 
Figure 13: Circular dichroism spectra of 4F at different peptide to lipid ratios (see Table 2). The peptide 
concentration was 176 µM 4F, except of sample 1, and the lipid-to-peptide ratio (R) is marked in the 
inset. The spectra suggest predominantly α-helical secondary structure, which even increased at higher 
lipid-to-peptide ratios. 
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1 588 0 - 
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Figure 14: Analysis of CD measurements with 4F (176 µM) at different peptide to lipid ratios (Table 2) 
by CDpro with three algorithms. The peptide is highly α-helical which increased at higher lipid 
concentrations drastically at the expense of β-structure and random coil parts. 
 
Isothermal titration calorimetry (ITC) 
 
Binding of the peptide 4F to lipid membranes 
 
Binding of the peptides to lipid vesicles was further investigated by means of ITC. 
Small or large unilamellar vesicles were prepared by sonication or extrusion procedure, 
respectively. The size and the monodispersity of the vesicles were determined by DLS 
measurements of diluted lipid vesicle suspensions (50 µM). LUVs (≈ 105 nm) were 
always monodisperse with a PDI of 0.05. On the other hand, SUVs (≈ 35 nm) showed a 
PDI of 0.25 - 0.3, even after variation of the sonication procedure. This is at the border 
of polydispersity as alluded to above. The size distribution (by volume) of 
representative DLS measurements of POPC SUVs and LUVs is shown in Figure 15. 
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The distribution analysis with SUVs showed the main peak at ≈ 35 nm and a second 
second small peak at ≈ 180 nm. In comparison, the analysis of LUVs indicated only the 
main peak at ≈ 105 nm. 
 
 
Figure 15: Size distribution by volume for POPC SUVs (A, 18.5 μM) and LUVs (B, 50 μM) determined 
by dynamic light scattering. 
 
A typical ITC titration is shown in Figure 16 A. Figure 16 A shows 2 µL injections 
(19 times) of POPC LUVs (5 mM) into 203 µL of 200 µM 4F dissolved in PBS buffer 
at 40 °C. The spacing of the injections was increased to a maximum of 300 s at lipid-to-
peptide ratios between 1 and 2 as a slow kinetics of this exothermic reaction was 
observed in this range.  
At the first injection probably most of the injected lipid was bound as 4F was in excess 
over lipid. As more vesicles were injected, the concentration of free peptide decreased, 
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and the heats of reaction became progressively smaller until all peptide was bound to 
lipid membranes. Further injections did not yield any significant heat changes. 
Integration of the heat flow over time resulted in the heat of binding for each titration 
step and is plotted as a function of the lipid-to-peptide ratio in Figure 16 B. The molar 
binding enthalpy of 4F is then determined from the total heat released in the titration (≈ 
-216.7 μcal) and the amount of peptide in the calorimeter cell (40.6 nmol). Therefore 
the heat of reaction is ΔH ≈ -5.34 kcal/mol for the experiment shown in Figure 16.  
For a complete thermodynamic characterization of the binding process including the 
binding constant, K, and the entropy, ΔS, the calorimetric data were analyzed with a 
multisite binding model, which was also used to describe the binding equilibrium of 
other peptides [20, 29]. In this model, the peptide is supposed to have n independent and 
equivalent binding sites for a ligand such as POPC. The binding model is represented by 
the following equation:  
 (1) 
 
[P] and [P]b are the concentrations of free and bound peptide, respectively, [L]t is the 
total concentration of ligand, that is POPC lipid. In the analysis, the lipid concentration 
[L]t may differ from the nominal concentration. This is caused by a peptide binding only 
to the vesicle outside (only 50 % of the lipid). In contrast 100 % lipid is available upon 
micellization The concentration of the lipid vesicles was varied in order to give 
consideration to the fact that only the outer lipid leaflet of intact vesicles is exposed to 
the peptides, whereas all lipids are exposed after micellization of vesicles. Practically 
this was done by to minimizing the mean square deviation of the fit at a fixed 
stoichiometry of n = 1. K is the intrinsic binding constant, and the stochiometry n is the 
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number of peptide molecules bound per ligand. The stoichiometry could also be derived 
directly from the experimental binding isotherm by the ratio at the midpoint of the 
transition. In consequence of mass conservation, the concentration of bound peptide can 
be described by the following equation:  
 (2) 
 
The index t denotes the total concentration of peptide and lipid in the calorimeter cell 
after each injection step. The peptide concentration changes during the titration with 
lipid vesicles due to dilution effects. The concentration of bound peptide is linked to the 
calorimetric data by the following equation: 
 (3) 
 
where δQi is the heat absorbed or released at the ith injection. ∆𝐻𝑝𝑒𝑝𝑡𝑖𝑑𝑒0  is the binding 
enthalpy of peptide, δ[P]b,i is the change (increase) in bound peptide concentration upon 
injection i, and V is the volume of the calorimeter cell. The solid line in Figure 16 is the 
best least-squares fit to the data using 1-3 with the following set of parameters: n = 1, K 
= 7.52 · 104 M-1, and ∆𝐻𝑝𝑒𝑝𝑡𝑖𝑑𝑒0  = -5.73 kcal/mol Table 3. ∆𝐻𝑝𝑒𝑝𝑡𝑖𝑑𝑒0  is consistent with 
the simple calculations given above. The entropy ΔS is calculated by the binding 
constant (calculated with K), the enthalpy of reaction and the temperature. 
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Figure 16: Example of a typical thermogram and binding isotherm of 5 mM POPC LUVs titrated into 
200 µM 4F at 40 °C in PBS buffer (+ 0.02 % NaN3). In A the heat flow due to the binding reaction is 
shown time dependently. The integrated peaks are depicted (B) in dependence of the lipid to peptide ratio 
and a binding model with n identical binding sites (ΔH = -5.73 kcal/mol, K = 7.52 · 104, n = 1) is fitted to 
the data. Buffer: PBS + 0.02 % NaN3. 
 
The binding reaction was measured at different temperatures ranging from 5 to 45 °C. 
Thermograms and binding isotherms are collected in the appendix (Figure 26) and 
thermodynamic parameters are summarized in Table 3. The heat flow of experiments 
with the two lowest temperatures (5 and 15 °C) was very small and reached almost the 
detection limit of the microcalorimeter. The reaction enthalpy decreased with increasing 
temperatures leading to a negative change of the heat capacity of ΔCp = -137 J mol-1·K-1 
as shown in Figure 17. The negative algebraic sign of the heat capacity change is a 
hallmark of hydrophobic interactions as driving force of the reaction [30, 31]. The 
binding constants K are in accordance with van`t Hoffs law, that changes only slightly 
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with the temperature in a range of K ≈ 5 • 104 M-1 within the errors of the measurement 
(Figure 18). Hence, also the Gibbs free reaction enthalpy does not change significantly. 
A decrease of enthalpy and entropy of reaction with increasing temperature at an almost 
constant Gibbs free enthalpy was observed. This process is called enthalpy-entropy-
compensation and found in many other reactions. Remarkable is the increase in lipid 
accessibility from about 70 to 90 % of the total lipid amount at 45 °C indicating almost 
complete dissolution of the vesicles (Table 3). 
 
 
Figure 17: Temperature dependency of the reaction enthalpy. Measurements of 5 mM POPC LUVs 
titrated into 200 µM 4F are shown. The change of heat capacity of -137 cal mol-1 K-1 is derived by the 
slope of the linear fit. The negative algebraic sign is a hallmark of hydrophobic interactions. 
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Figure 18: Binding constant of 4F to POPC LUVs in as a function of the reaction temperature. The 
binding constants of each measurements (red squares) are in the range of 4 · 104 M-1 and follow van`t 
Hoffs law (blue line). 
 
Binding of the peptide 4F to cholesterol 
 
The binding of the peptide 4F to cholesterol was also investigated in detail. Due to the 
poor solubility of cholesterol two strategies were chosen to make solution reactions 
possible. One was the incorporation of cholesterol into methyl-β-cyclodextrin rings as 
investigated by Herklotz et al. [32]. The other approach was the preparation of lipid 
vesicles with POPC and cholesterol. 
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Cholesterol in m-β-Cyclodextrin 
 
Cyclodextrins are cyclic oligosaccharides. In particular, β-cyclodextrin is composed of 
seven glycopyranoside units, which are topologically organized as a toroid with a 
smaller and a larger opening, exposing primary and secondary hydroxyl groups to the 
solvent. Hence the molecules are well soluble in water. The ring interior is less 
hydrophilic than the aqueous phase, facilitating the incorporation of hydrophobic 
molecules such as cholesterol. The methylated m-β-cyclodextrin has an enhanced 
affinity to cholesterol. In cell culture it is used together with cholesterol in order to load 
cells with cholesterol. 
Pure m-β-cyclodextrin (20 mM) or m-β-cyclodextrin (20 mM) containing 1 mM 
cholesterol were filled into the syringe of the titration calorimeter and were injected into 
a solution of 4F (100 µM) in the cell. Injection of pure m-β-cyclodextrin into peptide 
yielded relatively high (≈ 20 µcal) and a linearly decreasing heat release. This is typical 
for a dilution reaction and does not indicate direct binding of the peptide to m-β-
cyclodextrin (Figure 19, below). In contrast ITC experiments of m-β-cyclodextrin (20 
mM) with incorporated cholesterol (1 mM) shows the sigmoidal shape of a multi-site 
binding isotherm (Figure 19).  
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Figure 19: Titration of m-β-cyclodextrin into peptide 4F at 15 °C (I,III) and 5 °C (II). (A) Calorimetric 
traces were obtained by titration of cyclodextrin (20 mM) into 4F (100 µM). Cholesterol (1 mM) was 
complexed by cyclodextrin in (II) and (III). Each heat peak corresponds to injection of 10 µL 
cyclodextrin with or without cholesterol into the mircrocalorimeter cell. (B) Heats of reaction were 
obtained by integration of heat peaks and were plotted as a function of the peptide-to-cholesterol (I, II) 
and peptide-to-cyclodextrin (III) ratio, respectively. Buffer: 10 mM Hepes + 10 % DMSO. 
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Cholesterol in unilamellar vesicles 
 
The second approach was the preparation of lipid vesicles containing a well-defined 
cholesterol amount of cholesterol to elucidate the potential binding of cholesterol to the 
peptide 4F. LUVs were prepared using the extrusion method above 40 °C [33] in order 
to produce vesicles with a homogeneous distribution of cholesterol (5, 10 and 20 % 
cholesterol). The PDI of LUVs was about 0.05 in different buffers, increasing to about 
0.1 with cholesterol, whereas the diameter changed slightly from approximately 100 nm 
to approximately 110 nm. The vesicles were filled into the syringe at a concentration of 
5 mM and were injected into a solution of 200 µM peptide 4F at 40 °C as shown in 
Figure 20. The analysis was made with the same model as discussed above, resulting 
thermodynamic parameters are summarized in Table 3 and depicted in Figure 21. The 
reaction enthalpies clearly increased from -5697 to -2672 cal/mol with increasing 
cholesterol fractions (0 - 20 %, Figure 21), while the reaction entropy increased from 
3.06 to 10.6 cal mol-1 K-1. The binding constants were in the range of 104 M-1 and 
decreased linearly with increasing cholesterol fraction of the vesicles. The stoichiometry 
was n = 1 while the accessible lipid increased with increasing cholesterol percentage of 
the vesicles from 80 to 100 %. 
Measurements were also made with SUVs (Appendix Figure 27). POPC SUVs had a 
high polydispersity index PDI of about 0.3 which increased to 0.4 in presence of 
cholesterol. The diameter of the vesicles without cholesterol was about 35 nm with an 
accounting for approximately 90 % of total material. With an increasing cholesterol 
percentage the diameter increased to approximately 45 nm, whereas the fraction of these 
vesicles decreased to about 75 % of total lipid. More than 60 min sonication time 
yielded large particles in the range of 230 nm with a PDI of 0.14. 
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Figure 20: Titration of POPC LUVs with cholesterol into peptide 4F at 40 °C. (A): Calorimetric traces 
were obtained by titration of POPC LUVs (5 mM) with cholesterol (I: 5 %, II: 10 %, III: 20 %) into 4F 
(200 µM). Each heat peak corresponds to injection of 2 µL lipids into the mircrocalorimeter cell. (B): 
Heats of reaction were obtained by integration of heat peaks and were plotted as a function of the peptide-
to-lipid ratio. This experimentally obtained binding isotherm was fitted (I: ΔH = -4.06 kcal/mol, K = 6.40 
· 104, n = 1; II: ΔH = -3.53 kcal/mol, K = 4.20 · 104, n = 1; III: ΔH = -2.67 kcal/mol, K = 1.49 · 104, n = 1) 
with a multisite-binding model in (C). Buffer: PBS + 0.02 % NaN3. 
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Figure 21: Binding of peptide 4F to lipid vesicles (LUVs) containing cholesterol. Above: Reaction 
enthalpy of 4F to POPC/cholesterol LUVs as a function of cholesterol content. Below: Binding constants 
of 4F to POPC/cholesterol LUVs as a function of the cholesterol percentage. Multi-site binding model 
with a POPC:4F stoichiometry of n = 1. 
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Binding of the peptide P to lipid membranes 
 
Peptide P corresponds to a 4F dimer covalently bridged by a proline. It exhibits a 
greater in vivo HDL binding and anti-inflammatory potency [10]. In order to avoid 
aggregation of peptide P 10 % DMSO was added to the buffer. The experiments were 
performed with POPC LUVs as well as with SUVs. Lipid vesicles were filled into the 
syringe at a concentration of 3 mM (LUVs) and 1 mM (SUVs) and titrated into a 
solution of peptide P at a concentration of either 80 or 40 µM. The ITC titration results 
at 40 °C and the integrated heat peaks are shown in Figure 22. Conspicuous is the 
devolution of the heat flow during the first injection steps. The enthalpy first decreased, 
increased for a short period and then decreased again. One may speculate that an initial 
micellization reaction is reversed as more lipid is added. The experimental binding 
isotherm of reactions with LUVs and SUVs at 40 °C led to a binding constant of the 
order of 105 M-1 which was about one order of magnitude larger than that of the smaller 
peptide 4F. However, the stoichiometry is quite different with 2 and 0.4 and also the 
accessible lipid percentage of 65 and 100 % for LUVs and SUVs, respectively. In 
comparison to 4F the enthalpy of reaction is much more exothermic in case of 4F 
(4F/LUVs: ΔH = -5726 vs. P/LUVs: ΔH = -1751 kcal/mol, P/SUVs: ΔH = -3624 
kcal/mol, Table 3). 
However, reaction conditions were different, due to the presence of DMSO in solutions 
of the peptide P. Therefore experiments were also done with 4F and POPC LUVs in 
buffer with and without DMSO at 40 °C.  
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Figure 22: Titration of POPC LUVs and SUVs into peptide P at 40 °C. (A): Calorimetric traces were 
obtained by titration of POPC LUVs (I: 3 mM) and SUVs (II: 1 mM) into P (I: 80 µM, II: 40 µM). Each 
heat peak corresponds to injection of 10 µL (I) and 5 µL (II) lipids into the mircrocalorimeter cell. (B): 
Heats of reaction were obtained by integration of heat peaks and were plotted as a function of the peptide-
to-lipid ratio. This experimentally obtained binding isotherm was fitted with a multisite-binding model (I: 
ΔH = -1.75 kcal/mol, K = 9.87 · 104, n = 0.4; II: ΔH = -3.62 kcal/mol, K = 2.06 · 105, n = 2) in (C). 
Buffer: 10 mM Hepes + 10 % DMSO  
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Figure 23: Titration of POPC LUVs into peptide 4F at 40 °C. (A): Calorimetric traces were obtained by 
titration of POPC LUVs (3 mM) and into 4F (160 µM). Each heat peak corresponds to injection of 10 µL 
lipids into the mircrocalorimeter cell. (B): Heats of reaction were obtained by integration of heat peaks 
and were plotted as a function of the peptide-to-lipid ratio. This experimentally obtained binding isotherm 
was fitted with a multisite-binding model (ΔH = -8.93 kcal/mol, K = 4.8 · 104, n = 1) in (C). Buffer: 10 
mM Hepes + 10 % DMSO. 
 
Titration isotherms of 4F in the presence or absence of DMSO were very similar (0 % 
DMSO: K = 7.52 · 104 versus 10 % DMSO: K = 4.80 · 104 M-1) at a stoichiometry of 
n = 1. The enthalpy was more exothermic in presence of DMSO in the buffer (-8926 
versus -5726 kcal/mol), whereas the reaction entropy was dramatically smaller in the 
measurement with DMSO and changed sign (-7.09 versus 4.02 cal mol-1 K-1). 
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K = 3.84 · 104  vs. LUVs: K = 7.52 · 104 M-1) but quite different entropy and enthalpy 
values, consistent with earlier observations [34]. These results are similar to those 
obtained with the peptide P (SUVs: K = 2.06 · 105 vs. LUVs: K = 9.87 · 104 M-1). 
Nevertheless, more experiments are required before conclusive decisions can be made. 
 
  
Figure 24: Titration of POPC SUVs into peptide 4F at 40 °C. (A): Calorimetric traces were obtained by 
titration of POPC SUVs (1 mM) into 4F (100 µM). Each heat peak corresponds to injection of 5 µL lipids 
into the mircrocalorimeter cell. (B): Heats of reaction were obtained by integration of heat peaks and were 
plotted as a function of the peptide-to-lipid ratio. This experimentally obtained binding isotherm was 
fitted with a multisite-binding model (ΔH = -9.52 kcal/mol, K = 3.84 · 104, n = 1) in (C). Buffer: 10 mM 
Hepes + 10 mM DMSO. 
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Table 3: Summary of different ITC measurements with 4F and P together with POPC lipids at different reaction conditions. The thermodynamic parameters are listed on the 
right hand side of the table. Thermograms having a bad quality in terms of a sigmoidal binding isotherm are labeled by a star in the last column, but are listed anyway for the 
sake of completeness. 
peptide c(peptide) c(POPC(+Chol)) c(Chol) T buffer DMSO vesicles ΔH n Lipid K ΔS 
 
µM mM % °C 
 
% 
 
cal/mol 
 
% 
 
cal/mol/K 
             
4F 200 5 0 40 PBS 0 LUV -5726 1 70 7.52E+04 4.02 
4F 200 5 5 40 PBS 0 LUV -4064 1 80 6.40E+04 9.01 
4F 200 5 10 40 PBS 0 LUV -3530 1 100 4.20E+04 9.88 
4F 200 5 20 40 PBS 0 LUV -2672 1 100 1.49E+04 10.6 
        
 
 
 
 
 
4F 200 5 0 5 PBS 0 LUV -423 1 70 1.51E+05 22.2 
4F 200 5 0 15 PBS 0 LUV -1776 1 65 3.65E+04 14.7 
4F 200 5 0 25 PBS 0 LUV -3138 1 90 1.99E+04 9.15 
4F 200 5 0 35 PBS 0 LUV -4506 1 80 2.98E+04 5.85 
4F 200 5 0 45 PBS 0 LUV -5559 1 90 7.49E+04 4.82 
        
 
 
 
 
 
4F 100 1 0 40 HEPES 10 SUV -9518 1 75 3.84E+04 9.41* 
P 40 1 0 40 HEPES 10 SUV -3624 2 65 2.06E+05 12.7 
4F 160 3 0 40 HEPES 10 LUV -8926 1 75 4.80E+04 -7.09 
P 80 3 0 40 HEPES 10 LUV -1751 0.4 100 9.87E+04 17.3 
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1. Discussion 
 
Self-association 
 
 
Figure 25: Illustration of suitable velocities regarding analytical ultracentrifuge measurements seen in the 
manual of the Beckman centrifuge. The red circle shows the conditions used in the experiment shown in 
Figure 6. 
 
4F dissolved in 10 mM HEPES buffer without salt does not aggregate up to a 
concentration of 200 µM. The same holds true for the peptide dissolved in PBS buffer 
as evidenced by the DLS and AUC measurements. However, as depicted in Figure 25 
by the red circle at 42 krpm, sedimentation would not occur up to a molecular mass of 
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approximately 18 kDa. Thus peptide associates up to the size of octamers could still be 
present. This agrees with results obtained by DLS which excludes associates larger than 
hexamers. There are two possible types of self-associates. Firstly it could be reversible 
association equilibrium between monomers and oligomers depending on concentration 
and secondly, it could be an irreversible aggregation of peptide molecules. By diluting a 
reversible self-associate in a high sensitivity microcalorimeter, heat release of the 
dissociation reaction can be detected, like it has been described for self-associated Apo 
A-1 proteins (Chapter 3). Since most lipid binding experiments with ITC were 
performed at 40 °C, where no dissociation reaction could be detected this could not 
have biased our lipid binding results obtained by ITC.  
 
Lipid binding 
 
The binding of peptides 4F and P to POPC lipid vesicles was demonstrated by different 
types of experiments. The blueshift of the tryptophan fluorescence, the circular 
dichroism data as well as the ITC binding isotherms indicate consistently binding of the 
peptides to lipid membranes. Binding constants are of the order of 104 M-1 for the 
peptide 4F and ≈ 105 M-1 for peptide P. 
The thermodynamic parameters of the two peptides 4F and P where derived under 
slightly different conditions, due to the presence of DMSO in P-solutions. However, for 
4F binding to POPC LUVs the binding isotherms and derived binding constants were 
similar with or without DMSO in buffer (Table 3). In contrast, the reaction enthalpy and 
entropy differed clearly. The thermodynamic parameter of peptide binding to LUVs and 
SUVs were also different. This might be due to the less monodisperse characteristics of 
our POPC SUVs (PDI about 0.3) compared to the LUV preparations (PDI about 0.025). 
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4F Experiments done in the same buffer with the same temperature showed slightly 
smaller binding constants with lipids arranged in SUVs compared to those with LUVs. 
The binding constants of 4F to LUVs decreased with the percentage of cholesterol, 
while the reaction enthalpy was less exothermic (Figure 21). This is surprising since 
Apo A-1 and mimetic peptides are involved in cholesterol transport and –turnover. 
However, binding studies with cholesterol incorporated into cyclodextrin cavities, 
suggested binding of the peptide to cholesterol (Figure 19). A possible explanation 
would be that the affinity of the peptides to POPC lipids is strong to build HDL like 
particles, which bind weakly to cholesterol in vivo. Weak binding could be necessary to 
get rid of excess cholesterol for example at the liver to fulfill the function as a carrier 
through the blood stream. 
 
Thermodynamic interpretation 
 
The measured overall enthalpy as derived from ITC measurements with 4F and POPC 
LUVs is about -5.7 kcal/mol. Three different effects contribute to this measured value. 
1. A random coil/β-sheet&turn to α-helical transition, 2. hydrophibic interactions and 3. 
solvation of lipid vesicles. In the following each of these processes will be considered 
energetically. 
The results obtained by circular dichroism spectroscopy suggest a transition of random 
coil/β-sheet&turn segments to α-helical segments as driving force of lipid binding, like 
it is known from other peptides (penetratin [35], melittin [36]). Thermodynamically, we 
assume β-sheet and β-turn structure to be the same. The random coil to α-helix 
transition was investigated by Meier et al. and is known to be exothermic with 
approximately -800 cal/mol·residue. The β-sheet to random coil transition releases 
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between 0 - -600 cal/mol·residue, depending on the length of the segments [37, 38]. 
Multiplication of the changed fraction of secondary structural elements (α-helix → 
random coil; β-sheet → random coil) with the total residue number yields the number of 
changed segments (n = 5.22). Together with the above mentioned enthalpies this results 
in a transition enthalpy between -1.9 - -4.0 kcal/mol. The less exothermic the β-sheet to 
random coil transition enthalpy is assumed the more exothermic is the sum of the 
transition enthalpies. 
The ITC-results of the temperature dependence of reaction enthalpy showed clearly a 
negative change of heat capacity, meaning hydrophobic interactions are part of the 
driving force leading to lipid binding. 
The third process contributing to the measured reaction enthalpy is the micellization of 
lipid vesicles as proven by static light scattering. In case of POPC LUVs the process is 
endothermic with about 1.85 kcal/mol as investigated by Heerklotz et al. [39]. 
Subtracting this micellisation enthalpy of the measured reaction enthalpy 
remains -7.55 kcal/mol for the enthalpy of hydrophobic interactions and the secondary 
structural transition enthalpy. Subtraction of the transition enthalpy resulted in -3.55 - -
5.65 kcal/mol accounting for hydrophobic interactions. 
The transition of random-coil and β-sheet to α-helical secondary structural elements and 
hydrophobic interactions could clearly be addressed as driving force of 4F`s lipid 
binding. Yet balancing the percentage of each process was not achieved. 
  
3. Lipid binding of Apo A-1 mimetic peptides 
122 | P a g e  
 
References 
 
1. Tall AR: An overview of reverse cholesterol transport. Eur Heart J 1998, 19 
Suppl A:A31-35. 
2. Segrest JP, Garber DW, Brouillette CG, Harvey SC, Anantharamaiah GM: The 
amphipathic alpha helix: a multifunctional structural motif in plasma 
apolipoproteins. Adv Protein Chem 1994, 45:303-369. 
3. Segrest JP, Jackson RL, Morrisett JD, Gotto AM, Jr.: A molecular theory of 
lipid-protein interactions in the plasma lipoproteins. FEBS Lett 1974, 
38(3):247-258. 
4. Mendez AJ, Anantharamaiah GM, Segrest JP, Oram JF: Synthetic amphipathic 
helical peptides that mimic apolipoprotein A-I in clearing cellular 
cholesterol. J Clin Invest 1994, 94(4):1698-1705. 
5. Venkatachalapathi YV, Phillips MC, Epand RM, Epand RF, Tytler EM, Segrest 
JP, Anantharamaiah GM: Effect of end group blockage on the properties of a 
class A amphipathic helical peptide. Proteins 1993, 15(4):349-359. 
6. Datta G, Chaddha M, Hama S, Navab M, Fogelman AM, Garber DW, Mishra 
VK, Epand RM, Epand RF, Lund-Katz S et al: Effects of increasing 
hydrophobicity on the physical-chemical and biological properties of a class 
A amphipathic helical peptide. J Lipid Res 2001, 42(7):1096-1104. 
7. Sherman CB, Peterson SJ, Frishman WH: Apolipoprotein A-I mimetic 
peptides: a potential new therapy for the prevention of atherosclerosis. 
Cardiol Rev 2010, 18(3):141-147. 
3. Lipid binding of Apo A-1 mimetic peptides 
123 | P a g e  
 
8. Chung BH, Anatharamaiah GM, Brouillette CG, Nishida T, Segrest JP: Studies 
of synthetic peptide analogs of the amphipathic helix. Correlation of 
structure with function. J Biol Chem 1985, 260(18):10256-10262. 
9. Yancey PG, Bielicki JK, Johnson WJ, Lund-Katz S, Palgunachari MN, 
Anantharamaiah GM, Segrest JP, Phillips MC, Rothblat GH: Efflux of cellular 
cholesterol and phospholipid to lipid-free apolipoproteins and class A 
amphipathic peptides. Biochemistry 1995, 34(24):7955-7965. 
10. Wool GD, Vaisar T, Reardon CA, Getz GS: An apoA-I mimetic peptide 
containing a proline residue has greater in vivo HDL binding and anti-
inflammatory ability than the 4F peptide. J Lipid Res 2009, 50(9):1889-1900. 
11. Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, Eaton 
GM, Lauer MA, Sheldon WS, Grines CL et al: Effect of recombinant ApoA-I 
Milano on coronary atherosclerosis in patients with acute coronary 
syndromes: a randomized controlled trial. Jama 2003, 290(17):2292-2300. 
12. Ou J, Ou Z, Jones DW, Holzhauer S, Hatoum OA, Ackerman AW, Weihrauch 
DW, Gutterman DD, Guice K, Oldham KT et al: L-4F, an apolipoprotein A-1 
mimetic, dramatically improves vasodilation in hypercholesterolemia and 
sickle cell disease. Circulation 2003, 107(18):2337-2341. 
13. Peterson SJ, Husney D, Kruger AL, Olszanecki R, Ricci F, Rodella LF, 
Stacchiotti A, Rezzani R, McClung JA, Aronow WS et al: Long-term 
treatment with the apolipoprotein A1 mimetic peptide increases 
antioxidants and vascular repair in type I diabetic rats. J Pharmacol Exp 
Ther 2007, 322(2):514-520. 
14. Peterson SJ, Kim DH, Li M, Positano V, Vanella L, Rodella LF, Piccolomini F, 
Puri N, Gastaldelli A, Kusmic C et al: The L-4F mimetic peptide prevents 
3. Lipid binding of Apo A-1 mimetic peptides 
124 | P a g e  
 
insulin resistance through increased levels of HO-1, pAMPK, and pAKT in 
obese mice. J Lipid Res 2009, 50(7):1293-1304. 
15. Peterson SJ, Drummond G, Kim DH, Li M, Kruger AL, Ikehara S, Abraham 
NG: L-4F treatment reduces adiposity, increases adiponectin levels, and 
improves insulin sensitivity in obese mice. J Lipid Res 2008, 49(8):1658-1669. 
16. Bloedon LT, Dunbar R, Duffy D, Pinell-Salles P, Norris R, DeGroot BJ, Movva 
R, Navab M, Fogelman AM, Rader DJ: Safety, pharmacokinetics, and 
pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk 
cardiovascular patients. J Lipid Res 2008, 49(6):1344-1352. 
17. Watson CE, Weissbach N, Kjems L, Ayalasomayajula S, Zhang Y, Chang I, 
Navab M, Hama S, Hough G, Reddy ST et al: Treatment of patients with 
cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve 
select biomarkers of HDL function. J Lipid Res 2011, 52(2):361-373. 
18. Ziegler A, Seelig J: Contributions of glycosaminoglycan binding and 
clustering to the biological uptake of the nonamphipathic cell-penetrating 
peptide WR9. Biochemistry 2011, 50(21):4650-4664. 
19. Ziegler A, Seelig J: Binding and clustering of glycosaminoglycans: a 
common property of mono- and multivalent cell-penetrating compounds. 
Biophys J 2008, 94(6):2142-2149. 
20. Klocek G, Seelig J: Melittin interaction with sulfated cell surface sugars. 
Biochemistry 2008, 47(9):2841-2849. 
21. Sreerama N, Woody RW: Estimation of protein secondary structure from 
circular dichroism spectra: comparison of CONTIN, SELCON, and 
CDSSTR methods with an expanded reference set. Anal Biochem 2000, 
287(2):252-260. 
3. Lipid binding of Apo A-1 mimetic peptides 
125 | P a g e  
 
22. Jayaraman S, Abe-Dohmae S, Yokoyama S, Cavigiolio G: Impact of self-
association on function of apolipoprotein A-I. J Biol Chem 2011, 
286(41):35610-35623. 
23. Vitello LB, Scanu AM: Studies on human serum high density lipoproteins. 
Self-association of apolipoprotein A-I in aqueous solutions. J Biol Chem 
1976, 251(4):1131-1136. 
24. Swaney JB, O'Brien K: Cross-linking studies of the self-association 
properties of apo-A-I and apo-A-II from human high density lipoprotein. J 
Biol Chem 1978, 253(19):7069-7077. 
25. Gianazza E, Calabresi L, Santi O, Sirtori CR, Franceschini G: Denaturation 
and self-association of apolipoprotein A-I investigated by electrophoretic 
techniques. Biochemistry 1997, 36(25):7898-7905. 
26. Beck A, Li-Blatter X, Seelig A, Seelig J: On the interaction of ionic 
detergents with lipid membranes. Thermodynamic comparison of n-alkyl-
+N(CH) and n-alkyl-SO. J Phys Chem B 2010, 114(48):15862-15871. 
27. Lakowicz JR: Principles of fluorescence spectroscopy, 3rd edn. New York: 
Springer; 2006. 
28. Ladokhin AS, Jayasinghe S, White SH: How to measure and analyze 
tryptophan fluorescence in membranes properly, and why bother? Anal 
Biochem 2000, 285(2):235-245. 
29. Ziegler A, Blatter XL, Seelig A, Seelig J: Protein transduction domains of 
HIV-1 and SIV TAT interact with charged lipid vesicles. Binding 
mechanism and thermodynamic analysis. Biochemistry 2003, 42(30):9185-
9194. 
3. Lipid binding of Apo A-1 mimetic peptides 
126 | P a g e  
 
30. Murphy KP, Privalov PL, Gill SJ: Common features of protein unfolding and 
dissolution of hydrophobic compounds. Science 1990, 247(4942):559-561. 
31. Connelly PR, Thomson JA: Heat capacity changes and hydrophobic 
interactions in the binding of FK506 and rapamycin to the FK506 binding 
protein. Proc Natl Acad Sci U S A 1992, 89(11):4781-4785. 
32. Tsamaloukas A, Szadkowska H, Slotte PJ, Heerklotz H: Interactions of 
cholesterol with lipid membranes and cyclodextrin characterized by 
calorimetry. Biophys J 2005, 89(2):1109-1119. 
33. Heerklotz H, Szadkowska H, Anderson T, Seelig J: The sensitivity of lipid 
domains to small perturbations demonstrated by the effect of Triton. J Mol 
Biol 2003, 329(4):793-799. 
34. Seelig J: Thermodynamics of lipid-peptide interactions. Biochim Biophys 
Acta 2004, 1666(1-2):40-50. 
35. Persson D, Thoren PE, Lincoln P, Norden B: Vesicle membrane interactions 
of penetratin analogues. Biochemistry 2004, 43(34):11045-11055. 
36. Vogel H: Incorporation of melittin into phosphatidylcholine bilayers. Study 
of binding and conformational changes. FEBS Lett 1981, 134(1):37-42. 
37. Meier M, Seelig J: Length dependence of the coil <--> beta-sheet transition 
in a membrane environment. J Am Chem Soc 2008, 130(3):1017-1024. 
38. Meier M, Seelig J: Thermodynamics of the coil <==> beta-sheet transition in 
a membrane environment. J Mol Biol 2007, 369(1):277-289. 
39. Heerklotz H, Seelig J: Titration calorimetry of surfactant-membrane 
partitioning and membrane solubilization. Biochim Biophys Acta 2000, 
1508(1-2):69-85. 
  
3. Lipid binding of Apo A-1 mimetic peptides 
127 | P a g e  
 
Appendix 
 
 
0 1 2 3 4 5
-0.30
-0.20
-0.10
0.00
-0.10
-0.05
0.00
0.05
0 10 20 30 40 50 60 70
Time (min)
µc
al
/s
ec
Molar Ratio
KC
al
/M
ol
e 
of
 In
je
ct
an
t
 
0 1 2 3 4
-0.50
-0.45
-0.40
-0.35
-0.30
-0.25
-0.20
-0.15
-0.10
-0.05
0.00
Molar Ratio
KC
al
/M
ol
e 
of
 In
je
ct
an
t
 
0 1 2 3 4 5
-1.00
-0.50
0.00
-0.30
-0.20
-0.10
0.00
0.10
0 10 20 30 40 50 60 70 80
Time (min)
µc
al
/s
ec
Molar Ratio
KC
al
/M
ol
e 
of
 In
je
ct
an
t
 
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
-1.60
-1.40
-1.20
-1.00
-0.80
-0.60
-0.40
-0.20
0.00
0.20
Molar Ratio
KC
al
/M
ol
e 
of
 In
je
ct
an
t
 
  
C 
C 
A 
A 
B 
B 
I 
II 
3. Lipid binding of Apo A-1 mimetic peptides 
128 | P a g e  
 
 
0 1 2 3 4 5
-2.00
0.00
-0.60
-0.50
-0.40
-0.30
-0.20
-0.10
0.00
0.10
10 20 30 40 50 60 70 80 90
Time (min)
µc
al
/s
ec
Molar Ratio
KC
al
/M
ol
e 
of
 In
je
ct
an
t
0 1 2 3 4 5
-2.00
0.00
Molar Ratio
KC
al
/M
ol
e 
of
 In
je
ct
an
t
 
0 1 2 3 4 5
-2.00
0.00
-0.60
-0.50
-0.40
-0.30
-0.20
-0.10
0.00
0.10
10 20 30 40 50 60 70 80 90
Time (min)
µc
al
/s
ec
Molar Ratio
KC
al
/M
ol
e 
of
 In
je
ct
an
t
 
0 1 2 3 4 5
-4.00
-2.00
0.00
Molar Ratio
KC
al
/M
ol
e 
of
 In
je
ct
an
t
 
  
C 
C 
A 
A 
B 
B 
III 
IV 
3. Lipid binding of Apo A-1 mimetic peptides 
129 | P a g e  
 
 
0 1 2 3 4 5
-4.00
-2.00
0.00
-1.50
-1.00
-0.50
0.00
0 20 40 60 80
Time (min)
µc
al
/s
ec
Molar Ratio
KC
al
/M
ol
e 
of
 In
je
ct
an
t
 
0 1 2 3 4 5
-4.00
-2.00
0.00
Molar Ratio
KC
al
/M
ol
e 
of
 In
je
ct
an
t
 
Figure 1: Titration of POPC LUVs into peptide 4F at 5 °C (I), 15 °C (II), 25 °C (III), 35 °C (IV)and 45 °C 
(V). (A): Calorimetric traces were obtained by titration of POPC LUVs (5 mM) into 4F (200 µM). Each 
heat peak corresponds to injection of 2 µL lipids into the mircrocalorimeter cell. (B): Heats of reaction 
were obtained by integration of heat peaks and were plotted as a function of the peptide-to-lipid ratio. 
This experimentally obtained binding isotherm was fitted with a multisite-binding model (I: ΔH = -
0.42 kcal/mol, K = 3.81 · 104, n = 1; II: ΔH = -1.78 kcal/mol, K = 3.90 · 104, n = 1; III: 
ΔH = -3.14 kcal/mol, K = 4.05 · 104, n = 1; IV: ΔH = -4.51 kcal/mol, K = 4.28 · 104, n = 1; V: 
ΔH = -5.56 kcal/mol, K = 4.59 · 104, n = 1) in (C). Buffer: PBS + 0.02 % NaN3 
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Figure 2: Titration of POPC SUVs into peptide 4F and P at 40 °C. (A) Calorimetric traces were obtained 
by titration of POPC SUVs (1 mM) into 4F (I: 100 µM, III: 125 µM, V: 160 µM) and P (II: 70 µM, IV: 
65 µM, VI: 80 µM). Each heat peak corresponds to injection of 5 µL lipids into the mircrocalorimeter 
cell. (B) Heats of reaction were obtained by integration of heat peaks and were plotted as a function of the 
peptide-to-lipid ratio. Buffer: 10 mM Hepes + 10 % DMSO. 
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Preliminary manuscript 
 
Abstract 
 
ATP binding cassette transporter A1 (ABCA1) plays a key role in reverse cholesterol 
transport (RCT). Disorders of the RCT are affecting a large number of patients in form 
of atherosclerosis. ABCA1 flopps cholesterol from the inner to the outer membrane 
leaflet, where it is accepted by apolipoprotein A 1 (Apo A-1) and thus controls 
cholesterol homeostasis. Furthermore the transporter was reported to transport 
phosphocholines and vitamin E. This was mainly investigated in animal models and cell 
culture experiments. To further explore the ABCA1/allocrite interaction, the ATPase 
activity of inside-out vesicles obtained from ABCA1 transfected HEK293 cells was 
measured by means of a quantitative phosphate release assay. The specificity of the 
transporter was investigated by titration with putative allocrits of different chemical 
classes. Amphipatic compounds that carried a polyethyleneglycol (PEG) chain, a 
heterocyclic group and a hydrocarbon tail such as Tween80, Tween40 and the vitamin E 
derivatives TPGS400 and TPGS1000 showed increased activity of ABCA1. On the 
other hand, the stilbene derivatives DIDS and resveratrol decreased the activity of 
ABCA1 in a concentration dependent manner. Basal activity could not be inhibited by 
vanadate but aluminum fluorides were found to be strong inhibitors of the nucleotide 
binding sites (NBDs) of ABCA1. The present data shows that the activity of ABCA1 
can be enhanced or reduced in a concentration dependent manner with a relatively broad 
variety of substances. 
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Introduction 
 
Atherosclerosis is a syndrome affecting a large number of people worldwide. Since 
blood high-density lipoprotein (HDL) levels are inversely correlated to cardiovascular 
disease, factors associated with HDL metabolism are athereoprotective. One of these 
factors is the ATP-binding cassette transporter A1 (ABCA1). It is a 220 kDa integral 
membrane protein consisting of two transmembrane domains (TMDs) and two 
nucleotide-binding domains (NBDs). The catalytic cycle is assumed to be driven by 
ATP binding and hydrolysis. ABCA1 plays an essential role in the handling of cellular 
lipids. By promoting the transport of membrane phospholipids and cholesterol to lipid 
poor apolipoprotein acceptors, ABCA1 controls the formation of HDL and thus the 
whole process of cholesterol transport [1-3]. Cholesterol is an essential component of 
eukaryotic cells, at the same time however, hyper-accumulation of cholesterol is 
harmful. ABCA1 is mainly located on the plasma membrane but due to endocytosis and 
resecretion (retroendocytosis) of Apolipoprotein A-1 (Apo A-1) the transporter might 
also play a role in cellular lipid handling [4] and forming of HDL by pumping lipids 
into the vesicular lumen in which Apo A-1 is captured [5].  
Naturally occurring mutations in the ABCA1 gene cause Tangier disease, an autosomal 
recessive disorder of lipid metabolism and familial HDL deficiency [1]. The latter is 
mainly differentiated to Tangier disease by transmission as a dominant trait [1, 6-9].  
Regulation of the transporter takes place on transcriptional and posttranscriptional 
levels. The ABCA1 protein has a rapid turnover with a half-life of ABCA1 that was 
reported to be less than one hour in murine macrophage cells [10]. So far ABCA1 is 
mainly known to control lipid homeostasis by tight regulation of its protein level [11]. 
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In detail, induction of ABCA1 occurs by overloading cells with cholesterol through 
activation of the nuclear receptors liver X receptor (LXR) and retinoid X receptor. 
(RXR) [11]. ABCA1 protein levels also seem to be controlled by a degradation process 
[12-14]. As many proteins with a short life time ABCA1 is characterized by PEST 
sequences. The PEST motif features a proline (P), glutamate (E), serine (S), and 
threonine (T) sequence, and is usually flanked by lysine (K), arginine (R), or histidine 
(H) residues. A calpain protease seems to degrade the transporter via recognition of the 
PEST motifs. However, ABCA1 protein seems to be stabilized by ligands such as 
Apolipoprotein A-1 (Apo A-1). Apo A-1 binds directly to the transporter yielding 
increased ABCA1 protein levels but not mRNA levels [15].  
ABCA1 is expressed ubiquitously. However, cholesterol accumulation principally takes 
place in macrophages in the case of ABCA1 dysfunction [1]. Macrophages having 
accumulated plenty of cholesterol are called foam cells. Atheroma development and 
foam cell formation are significantly influenced by the expression level of ABCA1 in 
macrophages but largely independent of circulating HDL levels [1, 16, 17].  
A large number of studies were performed with ABCA1 either in cell culture or in 
clinical and animal trials. Nevertheless, detailed knowledge of the molecular function of 
ABCA1 as a membrane floppase is still lacking. The knowledge on molecules likely to 
be handled by the transporter was derived from experiments with polarized Caco-2 and 
various other cell monolayers, respectively. In most studies merely transport of 
cholesterol, phospholipids and vitamin E was investigated. The transport of 
phospholipids and cholesterol by ABCA1 was either assessed by transport assays with 
radioactively labeled compounds, detected in the extracellular medium or in acceptor 
particles like Apolipoprotein A-1/HDL [1, 18-19]. Transport of vitamin E and A was 
measured in bi-directional transport assays [1, 20]. While transport assays reveal the 
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apparent or net transport ATPase measurements reflect the effective transport (flopping 
rate) of ABCA1 [21]. Takahashi et al. present the only study of ABCA1 produced in 
insect cells and reconstituted in model membranes [22]. The transporter showed 
ATPase activity reconstituted in vesicles composed of different lipids and lipid mixtures 
(e.g. PC, PS and PG) as well as in a detergent-soluble form. The effect of other sterol 
compounds as well as cholesterol was tested by reconstituting ABCA1 in liposomes 
with a single concentration of the sterol compounds (20 %) as membrane constitutent. A 
mild inhibitory effect was observed for all investigated sterols. 
Here, we investigated ABCA1 in inside-out plasma membrane vesicles of ABCA1-
transfected HEK293 cells using a spectroscopic phosphate assay. The advantage of 
plasma membranes is that the protein remains embedded in its natural environment, in 
the proper orientation and conformation. In order to get more insight into the allocrite 
specificity of the transporter we chose a variety of different structures. The selected 
molecules have either structural similarities to well-known ABCA1 substrates such as 
cholesterol and phosphocholines (lyso-phosphocholines, phosphocholines, vitamin E, 
TPGS, estradiol) or are allocrites of other ABC transporters like P-glycoprotein 
(detergents). In some cases substances belong to both categories. In contrast to previous 
studies we also used compounds of other chemical groups such as detergents. 
Furthermore, all compounds were measured over a broad concentration range.  
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Materials and methods 
 
Cell lines and cell culture 
 
The human embryo kidney cells Flp In HEK293 (HEK293-WT) transfected with the 
human ABCA1 gene (HEK293-ABCA1) were generously provided by Matthew Wright 
from F. Hoffmann-La Roche Ltd., Basel. The mRNA level of the ABCA1 transporter 
was 21000 fold higher in transfected than in untransfected cells, in which the transporter 
is essentially undetected. An ABCA1 protein level of transfected cells was estimated by 
Wright et al. on basis of a cholesterol efflux activity assay. The pump rate was 
approximated by one molecule cholesterol per transporter per second. The result is a 
protein level of 105 ABCA1 transporters per cell.  
Cells were maintained in monolayer culture in sterile culture flasks (Costar, 25–75 cm2) 
at 37 °C in an air atmosphere containing CO2 (5 %) and featuring a humidity saturation 
of 100 %. DMEM medium was supplemented with fetal bovine serum (10 % v/v), 
penicillin (100 units/ml), streptomycin (100 ug/ml) and L-glutamine (146 mg/L). The 
transfected cells were grown in presence of the selection antibiotic Hygromycin B 
(100 ug/ml). Both cell lines were passaged every 3-4 days. Cell counting was performed 
with a hemocytometer.  
 
4. Towards understanding of the allocrite specificity of the lipid floppase ABCA1 
139 | P a g e  
 
Plasma Membrane Vesicle Preparation 
 
Cells were washed with PBS buffer and scraped in ice-cold PBS, charged with protease 
inhibitors (1 tablet/50 ml buffer). For lysis the cells were washed with hypotonic lysis 
buffer (10 mM Tris-HCl, pH 7.5, 10 mM NaCl, 1 mM MgCl2, 1 protease inhibitor 
cocktail tablet/50 mL) and were centrifuged at 2100 gmax for 10 min at 4 °C. The pellet 
was resuspended in lysis buffer (1.25 ml per each 15 cm dish). Cell disruption was 
performed at 400 bar in a “One Shot” cell disrupter (Constant Systems Ltd., 
Warwickshire, U.K.). The cell lysate was then diluted 1:1 with ice-cold isotonic buffer 
(10 mM Tris-HCl, pH 7.4, 250 mM sucrose, 50 mM N-methyl-D-glucamine, NMDG, 1 
protease inhibitor cocktail tablet/50 mL buffer). Unbroken cells and the nuclei were 
precipitated by centrifugation at 800 gmax for 10 min at 4 °C. Afterwards mitochondria 
were removed by centrifugation at 6000 gmax for 10 min at 4 °C. The crude membranes 
were pelleted with the last centrifugation step at 100000 gmax for 1 hour at 4 °C. The 
pellet was resuspended with the isotonic buffer and homogenized by aspiration and 
dispension cycles with a 23-gauge syringe. The preparation was frozen rapidly in liquid 
nitrogen and stored at -80 °C. The overall protein content of the membranes was 
determined to be 8.6 ± 2.7 mg/ml (average of different preparations) by a BCA protein 
assay with bovine serum albumin as standard. 
 
Linearity of the ATP-hydrolysis 
 
The linearity of the ATP hydrolysis was checked by a slightly modified phosphate 
release assay. Three samples of each 4.5 ml phosphate release mixtures were placed in a 
water bath at 37 °C and aliquots of 100 uL were removed at different times. The 
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reaction of those aliquots was immediately quenched by cooling in an ice-bath and 
addition of 333 uL stop solution. After subsequent incubation at room temperature at 37 
°C for 30 min and transfer of 260 uL to a 96-well microtiter plate (Nunc F96 MicroWell 
plate, nontreated) the formed phosphate molybdate complex was measured at 820 nm in 
a Spectramax M2 (Molecular Device, Sunnyvale, CA). 
 
Phosphate release assay 
 
The inorganic phosphate release of the ABCA1 ATPase was measured according to 
Litman et al. (1997) and Äänisma et al. (2008) [23-25] in 96-well microtiter plates 
(Nunc F96 MicroWell plate, nontreated, wells at the border were not considered for 
analysis) with small modifications. The crude membranes were thawed and diluted to 
0.1 mg/ml protein concentration in ice-cold phosphate release assay buffer (25 mM 
Tris-HCl including 50 mM KCl, 3 mM ATP, 2.5 mM MgSO4, 3 mM DTT, 0.5 mM 
EGTA, 2 mM ouabain, and 3 mM sodium azide, pH 7.0). The total assay volume was 
60 µL/well, containing 5 µg/well of protein. The reaction with and without possible 
allocrites was started by transferring the plate into a water bath kept at 37 °C for 1 hour 
and was quenched by rapidly cooling the plate on ice and the addition of an ice-cold 
stopping solution (200 µL/well, ammonium molybdate (0.2% (w/v)), sulfuric acid 
(1.43% (v/v)), freshly prepared ascorbic acid (1% (w/v)), and SDS (0.9% (w/v)). The 
concentration of inorganic phosphate (Pi), resulting from the hydrolysis of ATP was 
determined by colorimetric quantification after 30 min incubation at room temperature. 
The formed phosphate molybdate complex was quantified at λ = 820 nm in a 
Spectramax M2 (Molecular Device, Sunnyvale, CA). To inhibit the ABCA1 ATPase 
selectively, samples were incubated either with aluminum fluorides (1.7 mM 
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[ADP·Al·F]; prepared from aqueous solutions of 1 mM NaF, 100 mM AlCl3 and 91.1 
mM ADP mixed in this order to gain 20.66 mM of the complex) or vanadate (0.5 mM) 
to subtract from the measurements. As vanadate inhibited only partially control samples 
without compounds were kept on ice and were subtracted from the measurements. The 
colorimetric result was calibrated using reference phosphate standards included in each 
microtiter plate. Compounds tested were obtained from Avanti lipids or Sigma-Aldrich. 
 
Modified phosphate release assay 
 
The inhibition assay is based on the phosphate release assay with some simplifications. 
The mixtures were prepared in parallel on a 96-well microtiter plate (Nunc F96 
MicroWell plate, nontreated). Crude membranes were thawed and diluted to 0.1 mg/ml 
protein concentration in ice-cold phosphate release assay buffer (25 mM Tris-HCl 
including 50 mM KCl, 3 mM ATP, 2.5 mM MgSO4, 3 mM DTT, 0.5 mM EGTA, 2 
mM ouabain, and 3 mM sodium azide, pH 7.0). The total assay volume was 60 µL/well, 
featuring 5 µg/well of protein. The absorbance of the molybdate complex was 
determined at eight different concentrations of the inhibitor in presence and as a control 
in absence of crude membranes. The reaction with and without possible allocrites was 
started by transferring the plate into a water bath kept at 37 °C for 1 hour and was 
quenched by rapidly cooling the plate on ice and the addition of an ice-cold stopping 
solution (200 uL/well, ammonium molybdate (0.2% (w/v)), sulfuric acid (1.43% (v/v)), 
freshly prepared ascorbic acid (1% (w/v)), and SDS (0.9% (w/v)). The absorbance of 
the inorganic phosphate Pi, resulting from the hydrolysis of ATP was determined by a 
colorimetric quantification after 30 min incubation at room temperature. The phosphate 
molybdate complex formed was quantified at 820 nm in a Spectramax M2 (Molecular 
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Device, Sunnyvale, CA). An absorbance value of samples with ATP, compound and 
crude membranes at different concentrations was measured. The pH value of sample 
solutions were checked and adjusted if necessary. Samples without membranes were 
incubated in parallel in order to correct for unspecific ATPhydrolysis in all 
measurements. Measurements were performed in duplicate on the microtiter plate. The 
absorbance of the basal activity was calculated as an average of four samples with crude 
membranes and ATP.  
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Results 
 
Linearity of the ATP-hydrolysis 
 
The linearity of ATP hydrolysis of inside-out plasma membrane vesicles 
(HEK293-ABCA1) over time was tested in order to optimize the reaction time of the 
phosphate release assay. Experiments were performed in phosphate realase assay buffer 
at 37°C without any compounds. The basal activity was measured up to two hours. In 
Figure 1 the absorbance of the molybdate phosphate complex at λ = 820 nm is shown as 
a function of time. The absorbance increased linearly from ~ 0.1 to ~ 0.9. The linear fit 
to the absorbance versus time data is within the limit of error, proving the linearity of 
the ATP hydrolysis. 
 
Figure 1 
 
Phosphate release assay 
 
The compounds investigated can be divided into four main classes. (I) short chain 
phosphocholines (PC) and lyso-phosphocholines (lyso-PC), (II) detergents, which 
interact with Pgp [26, 27], (III) vitamin E [20] and its derivatives TPGS400 and 
TPGS1000, and (IV) the stilbenes resveratrol, DIDS and estradiol. HEK-ABCA1-
inside-out vesicles were titrated at 37°C. The results for all experiments performed are 
summarized in Table 1 and the fold of activation as a function of the putative allocrite 
concentration is shown in the Appendix. Lyso-PC and PC lipids, the steroid hormone 
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and vitamin E were tested below the critical micellar(/aggregation) concentration 
(CMC) and showed no reproducible effects in the phosphate release assay. Repetition of 
the assay with identical putative allocrites revealed significant deviating data (≤ 50 %) 
in some cases. 
 
Table 1 
 
Effects on the ATPase activity were observed with compounds classified as detergents, 
vitamin E derivatives and stilbenes. 
Several detergents were used below and also above the CMC as shown in Table 1 and 
in the appendix. Note that the CMC could change under different conditions. At the 
CMC a small increase of activation (≤ 5 %) was observed occasionally (n-decyl-β-D-
glucopyranosid, CHAPS, C12EO8). The small increase in activity arises due to vesicle 
lysis above the CMC and the concomitant exposure of originally occluded NBDs [28]. 
N-decyl-β-D-glucopyranosid showed contradicting effects (activation/inhibition) in 
different assays at higher concentrations and was not further evaluated. 
Further effects are grouped into compounds that caused (i) decreased activity below the 
CMC, (ii) decreased activity above the CMC and (iii) increased activity above the CMC 
in the phosphate release assay. Increased activity below the CMC was not observed 
with any tested compound. 
(i) Stilbenes tested (resveratrol and DIDS (4,4'-Diisothiocyano-2,2'-stilbenedisulfonic 
acid)) decreased the activity in the phosphate release assay and in its modified version, 
respectively (Figure 2, Table 1 and Appendix). DIDS decreased the activity to about 
10 % of basal activity, whereas resveratrol inhibited only to about 75 %. In Figure 3 the 
absorbance of the inhibition assay with DIDS is shown as a function of the 
4. Towards understanding of the allocrite specificity of the lipid floppase ABCA1 
145 | P a g e  
 
concentration. While the absorbance of samples with membranes decreased, samples 
without membranes did not show any decrease of absorbance with increasing DIDS 
concentrations. Hence, an artifact due to interaction of the phosphate molybdate 
complex with the compound could be ruled out. The absorbance of the samples without 
membranes is due to the color complex, which was formed by traces of phosphate in the 
ATP preparation. 
 
Figure 2 
 
Figure 3 
 
(ii) The detergents CHAPS, Triton X-100 and C12EO8 showed decreasing activity above 
their CMC in the phosphate release assay (Table 1 and Appendix). CHAPS decreased 
the activity strongly down to ~ 10 %, whereas Triton X-100 and C12EO8 indicated 
slightly decreased activity (~ 80 %). Inhibitory effects of detergents above the CMC are 
generally assumed to be unspecific. However, the strong inhibiting effect of CHAPS 
compared to other tested detergents above the CMC could be a hint of specific 
interaction with ABCA1. A specific effect is confirmed by repetition of the experiment 
(CHAPS and C12EO8) with inside-out-vesicles prepared from HEK293-WT cells that 
did not show any effect. 
(iii) The detergents Tween80 and Tween40 and the vitamin E derivatives TPGS400 and 
TPGS1000 showed increased activity above its CMC in the phosphate release assay 
(Table 1, Figure 4 and Appendix). The increased ATPase activity of the transfected 
inside-out vesicles was ~ 140 % with Tween80, ~ 130 % with TPGS1000, ~ 140 % with 
Tween40 and ~ 115 % with TPGS400. These compounds are all characterized by an 
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amphiphillic structure composed of a hydrophilic polyethylene glycol (PEG) chain, a 
heterocyclic group and a relatively long hydrophobic aliphatic hydrocarbon chain. 
Activation above the CMC could be a sign of very low affinity of these allocrits to the 
transporter, analogous to the ABC transporter SAV1866 (Andreas Beck, Päivi 
Äänismaa and Anna Seelig; unpublished). Low affinity requires a high concentration of 
the allocrite in the membrane, as it occurs above an allocrite`s CMC. 
 
Figure 4 
 
Modified phosphate release assay 
 
Putative inhibitors of the NBDs of HEK293-ABCA1 cells were tested by means of a 
modified phosphate release assay. Generally, vanadate and aluminum fluoride 
complexes are inhibitors of nucleotide binding domains (NBDs) due to its chemical 
analogy to phosphate. The result of the inhibition assay is illustrated in Figure 2. The 
basal activity of the transfected inside-out vesicles is plotted against the logarithm of the 
inhibitor concentration and shows a linear dependence. Therefore inhibition followed an 
exponential rule. Vanadate, which is a capable inhibitor of the ATPase of P-glyco-
protein [30] did not fully inhibit ABCA1 ATPase activity (35 %). In contrast, aluminum 
fluorides and DIDS showed inhibition to less than 10 %. Until now it is unclear whether 
DIDS is interacting with the NBDs, whereas aluminum fluorides and vanadate are 
known to inhibit the NBDs [31].  
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Discussion and conclusions 
 
The copy number of ABCA1 proteins per HEK293-ABCA1 cell is estimated to be 105. 
This is ten times lower than in MDR1 transfected mouse embryo fibroblasts NIH-
MDR1-G185. Therefore, relatively small increasing effects on the activity were 
measured in the phosphate release assay. 
The small activating effect of less than 5 % after lysis of the inside-out vesicles at the 
CMC of several detergents indicates a high percentage of inside-out vesicles compared 
to right-side-out vesicles. 
The endogenous allocrits PCs and vitamin E as well as Lyso-PCs did not show any 
effect. This could either mean that these compounds are not transported or that they are 
transported with basal activity. 
DIDS and resveratrol, both carry a stilbene group. The compounds affected decreased 
activity in the phosphate release assay and in its modified version, the inhibition assay, 
respectively. The effect of resveratrol was also found for Pgp in inside-out vesicles 
made of NIH cells transfected with Pgp (NIH-MDR1-G185). But the effect was not 
observed with inside-out vesicles made of wildtype NIH cells (NIH-3T3) (PGP and 
wiltype: Xiachun Li-Blatter and Anna Seelig; unpublished results) suggesting a specific 
effect on ABCA1. Since the concentrations of half-maximum activation, K1, for the two 
transporters Pgp and ABCA1 were virtually identical and DIDS (pKa: -3.21, -1.43, -
0.37, 0.23) does not insert into the lipid bilayer an interaction with the NBDs is more 
likely than an interaction with the TMDs.  
The activity of ABCA1 was decreased by many detergents near or above the CMC. This 
is generally assumed to be an unspecific effect. Nevertheless, a specific effect cannot be 
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excluded since detergents very often stabilize membrane proteins and have specific 
effects to ABC transporters [26]. 
Tween and TPGS are amphiphillic compounds that are featured by a PEG chain, a 
heterocyclic group and a hydrocarbon chain as common structural elements and showed 
activation in the phosphate release assay with ABCA1 above the CMC. In contrast, 
these substances inhibited Pgp activity below the CMC [26, 32]. Activation above the 
CMC could be a sign of low affinity of the transporter to TPGS and Tween as eluded 
above (chapter: results). Low affinity of ABCA1 to allocrits could be a general feature 
of these interactions. Regarding the high concentrations of phospholipids and 
cholesterol in lipid membranes, a low affinity of ABCA1 to these allocrites is probably 
physiologically necessary to fulfill its function as efflux transporter. High affinity and 
high concentrations would yield inhibition of the transporter [25]. Furthermore it is in 
agreement with the study of Takahashi et al. [22] who measured compounds in mixed 
vesicles at high concentrations (e.g. steroids at 20 % w/w). On the other hand, activation 
above the CMC could also be an effect due to changed membrane parameters. However, 
Tween80 yields a lower, whereas TPGS leads to higher packing density of the 
membrane [33] but both compounds increased the activity in the phosphate release 
assay suggesting a specific interaction with the transporter. The assumption of a specific 
effect is also supported by the fact that all tested detergents changed membrane 
parameters but most of them showed decreasing activity. 
Compared to Pgp, which interacts with a lot of different molecules via hydrogen bond 
formation [34, 35] ABCA1 seems to be more specific to its allocrits.  
Aluminum fluorides and vanadate are typical inhibitors of NBDs due to their phosphate 
mimicking characteristics. Several ABC transporters and other nucleotide triphosphate 
hydrolysing proteins are known to be inhibited by aluminum fluorides (AtABCD1, 
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MRP1, G-proteins) [30, 36, 37]. Vanadate is commonly used in the phosphate release 
assay with Pgp overexpressing cells at a concentration of 0.5 mM in order to inhibit Pgp 
ATPase activity almost completely. At this concentration ABCA1 was only inhibited to 
~ 55 % by vanadate. This is in agreement with investigations of Takahashi et al. [22]. 
The lack of vandate sensitivity observed in our assays proves a specific measurement of 
the ABCA1 ATPase. Vanadate and aluminum fluorides are both inhibitors arresting the 
enzyme in similar ATP hydrolysis transition states [30]. Even though, different 
vanadate sensitivity may mean that the NBDs of Pgp hydrolyze ATP on a different 
mechanism than ABCA1. 
 
4. Towards understanding of the allocrite specificity of the lipid floppase ABCA1 
150 | P a g e  
 
Legends to the figures 
 
Figure 1: ATP hydrolysis of HEK-ABCA1 inside-out vesicles measured by 
quantification of inorganic phosphate released. The absorbance of the molybdate-
phosphate complex was measured at 820 nm and is plotted against the time of 
hydrolysis. 
 
Figure 2: The graphs show inhibition of the basal activity of HEK293-ABCA1 inside-
out plasma membrane vesicles in a phosphate release assay as a function of the tested 
compound concentration. Tested compounds were vanadate (A), aluminum fluorides 
(B) and DIDS. The activity decreased linearly with the concentration for all three 
substances in a semi logarithmic plot. However, vanadate decreased to about 30 %, 
whereas aluminum fluorides and DIDS decreased the activity to less than 10 % in the 
concentration range measured. 
 
Figure 3: The absorbance of the molybdate-phosphate complex formed is shown in 
dependence of the concentration of DIDS. The samples without inside-out vesicles 
(blue points) show approximately constant absorbance values, whereas the difference of 
absorbance of samples with ATP and without (see materials and methods) is decreasing 
linearly in this semi logarithmic plot. 
 
Figure 4: TPGS400 (A) and TPGS1000 (B) were measured with the phosphate release 
assay. The normalized activity of one measurement is plotted as a function of the 
compound concentration. The error bars represent the differences of duplicates. The 
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CMC of both compounds lies at a concentration of. ~ 10 µM. Both compounds showed 
slight activation at concentrations above the CMC. 
 
Table 1: Summary of putative allocrites tested in phosphate release assays with inside-
out vesicles of ABCA1 transfected HEK293 cells. Ice samples were subtracted in 
experiments in which vanadate was used to inhibit the ATPase. Critical micellar 
concentrations (CMC) or critical aggregation concentrations were obtained from Li-
Blatter et al. [26] (#), Stafford et al. [29] (*) and the Avanti lipid hompage 
(http://avantilipids.com/index.php?option=com_content&view=article&id=1703&Itemi
d=422) (+). The remaining CMCs are from unpublished results generously provided by 
Xiachun Li-Blatter and Anna Seelig. Concentrations above the CMC are colored in red. 
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Figures and Tables 
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Figure 2 
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Figure 3 
 
 
Figure 4 
  
0
0.1
0.2
0.3
0.4
0.5
0.01 0.1 1 10
ab
so
rb
an
ce
 a
t 8
20
 n
m
 
c(DIDS) / mM 
0.6
0.8
1.0
1.2
1.4
1.E-01 1.E+00 1.E+01 1.E+02 1.E+03
no
rm
al
ize
d 
ac
tiv
ity
 
Conc / µM 
A 
0.8
0.9
1.0
1.1
1.2
1.3
1.E-01 1.E+00 1.E+01 1.E+02
no
rm
al
ize
d 
ac
tiv
ity
 
Conc / µM 
B 
4. Towards understanding of the allocrite specificity of the lipid floppase ABCA1 
160 | P a g e  
 
Table 1 
group compound kinase inhibit. 
approx.. max. 
activation  
/ % 
approx. 
max. 
inhibition 
/ % 
conc. 
range / 
µM 
CMC / 
µM 
       
Lyso PCs 8 Vanadate - - 5-5335 60000+ 
 8 Vanadate - - 5-5335 60000
+ 
 10 Vanadate - - 7.3-2912 7000
* 
 10 Vanadate - - 1.4-564 7000
* 
 12 Vanadate +  - 0.6-337 700
* 
 12 Vanadate - - 0.6-334 700
* 
PCs 8 Vanadate - - 0.6-380 270+ 
 8 Vanadate - - 0.6-381 270
+ 
 8 Vanadate - - 0.6-382 270
+ 
 8 in DMSO Vanadate - - 2.1-4168  
 8 in DMSO Vanadate - - 2.1-4169  
 8 Vanadate - - 0.4-251 270
+ 
 8 Vanadate - - 0.4-251 270
+ 
 8 Vanadate - - 0.6-387 270
+ 
 9 Vanadate - - 0.1-58 29
+ 
 9 Vanadate - - 0.1-58 29
+ 
Detergents C12EO8 Al·F- Δ≤ 5 at CMC 80 0.7-747 90# 
 C12EO8 Al·F
- Δ ≤ 5 at CMC 80 0.7-747 90# 
 C12EO8 Vanadate Δ ≤ 5 at CMC 80 0.7-747 90
# 
 C12EO8 Vanadate Δ ≤ 5 at CMC 90 0.7-747 90
# 
 CHAPS low Vanadate  - 2.8-5529 10000
# 
 CHAPS low Vanadate  - 2.8-5530 10000
# 
 CHAPS high Vanadate Δ ≤ 5 at CMC 20 39-78823 10000
# 
 CHAPS high Vanadate Δ ≤ 5 at CMC 5 39-78823 10000
# 
 CHAPS high Al·F
- Δ ≤ 5 at CMC  20  39-78823 10000# 
 
n-decyl-β-
gylcopyranosid Vanadate Δ ≤ 5 at CMC 75 6.3-2542 2200
# 
 
n-decyl-β-
gylcopyranosid Vanadate 
110 and ≤ 5 at 
CMC - 6.3-2543 2200
# 
 Triton X-100 Vanadate - 80 2.2-886 300
# 
 Triton X-100 Vanadate - 80 2.2-887 300
# 
 Tween40 Vanadate 120 - 0.3-105 27# 
 Tween 80 Vanadate 105 - 0.03-11.9 12
# 
 Tween 80 Vanadate 105  - 
0.03-
11.10 12
# 
 Tween 80 Vanadate 140  - 0.14-56 12
# 
Vitamin E – 
(derivatives) Vitamin E Vanadate - - 0.1-77  
 Vitamin E Vanadate - - 0.1-78  
 TPGS 1000 Vanadate 140 - 0.1-81 ~ 10 
 TPGS 1000 Vanadate 125 - 0.1-81 ~ 10 
 TPGS 400 Vanadate 115 - 0.4-172 ~ 10 
 TPGS 400 Vanadate 115 - 0.4-172 ~ 10 Steroids Estradiol Vanadate - - 1.7-2000 ~ 1400 
 Estradiol Vanadate - - 4.6-5512 ~ 1400 
Stilbenes Resveratrol Vanadate - 60 0.5-616 ~ 680 
 Resveratrol Vanadate - 70 0.5-610 ~ 680 
 DIDS modified assay - 10 25-3210  
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Appendix 
 
Fold vs. concentration plots of all measured compounds in the phosphate release assay. 
Measurements of the lowest and the highest concentration should not be taken into 
account as they are from wells at the edge of the 96-well plates. 
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